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Abstract
The purpose of this thesis was to develop tools for studying oxygen-dependent reg-
ulation of red blood cell (RBC) flow distribution in the microcirculation. At the
microvascular level, arterioles dictate the distribution of oxygen (O2) carrying RBCs
to downstream capillaries, a process which needs to be tightly regulated and cou-
pled to O2 off loading from capillaries to the tissue. To investigate potential regula-
tory mechanisms, an O2 exchange platform was developed to manipulate the RBC
hemoglobin O2 saturation (SO2) at the muscle surface while limiting the changes in
SO2 to only a single capillary network. Decreasing SO2 in a single capillary net-
work resulted in an increase in supply rate, while increasing SO2 caused a decrease
in supply rate. This finding is consistent with our hypothesis that ATP released in
capillaries in response to low SO2 is responsible for vasodilation of upstream arterioles
to regulate blood flow. To determine whether the dynamics of ATP was fast enough
to enable RBC signalling in capillaries, an in vitro microfluidic system was developed
to generate a rapid decrease in RBC SO2. The feasibility of this experimental design
was first tested computationally using a mathematical model that consisted of blood
flow, oxygen and ATP transport as well as a model for hemoglobin binding, ATP
release, ATP/luciferin/luciferase reaction and digital camera light detection. The
model demonstrated that the concept was theoretically feasible and yielded impor-
tant insights such as the signal sensitivity to flow rate. The model further revealed
that measured light intensity levels would not be directly related to ATP concentra-
tions, thus, care must be taken when interpreting the data. It was determined that
the microfluidic device would be fabricated using soft lithography techniques that
resulted in a device that differed significantly from our original theoretical design
since all of the layers would be oxygen permeable except for a glass coverslip with a
small opening for gas exchange between the liquid and gas channel. To optimize the
geometric design of this microfluidic device, to maximize the desaturation the RBCs,
a finite element model was developed. Based on this design a device was constructed.
To test whether the design generated a rapid decrease in RBC SO2, a low hematocrit
high SO2 RBC suspension was perfused through the device exposed to 95% N2 and
5% CO2 in the gas channel. Finally, to overcome challenges with existing approaches
for measuring SO2 in the device, a novel image analysis technique using digital in-
painting was developed. The inpainting approach demonstrated a rapid change in
RBC SO2 at the entrance to the window, thus the microfluidic device is ready to be
used to measure the dynamics of O2-dependent ATP release from RBCs. The new
inpainting algorithm was also applied to in vivo video sequences where it was shown
i
to provide more accurate SO2 measurements and to work under conditions where
existing approaches fail. In summary, this thesis provides a set of in vivo, in vitro
and computational tools that can be used to study the mechanisms of SO2-dependent
regulation of the microvascular blood flow.
Keywords: oxygen regulation, red blood cells, hemoglobin oxygen sat-
uration, microcirculation, computational modelling, microfluidics, image
processing
ii
The Co-Authorship Statement
A version of the second chapter titled “Localized oxygen exchange platform for in-
travital video microscopy for the investigation of microvascular oxygen regulation” is
in preparation for publication. This article was co-authored by Stephanie Milkovich,
Hristo Nikolov, David Holdsworth, Graham Fraser, and Christopher Ellis.
A version of the third chapter titled “A Computational Model of a Microfluidic De-
vice to Measure the Dynamics of Oxygen-Dependent ATP Release from Erythrocytes”
was published in PLoS One. This article was co-authored by Nour Ghonaim, Daniel
Goldman and Christopher Ellis.
A version of the fourth chapter titled “Finite Element Model of Oxygen Transport for
the Design of Geometrically Complex Microfluidic Devices Used in Biological Stud-
ies” was published in PLoS One. This article was co-authored by Graham Fraser,
Daniel Goldman and Christopher Ellis.
A version of the fifth chapter titled “Using digital inpainting to estimate incident
light intensity for the calculation of red blood cell oxygen saturation from microscopy
images” was accepted to the Journal of Biophotonics. This article was co-authored
by Nicole Drakos, Graham Fraser and Christopher Ellis.
A version of the sixth chapter titled “Microfluidic Device for the Rapid Oxygen Desat-
uration of Hemoglobin in Red Blood Cells: A Tool for Studying Oxygen-Dependent
ATP Release” is in preparation for publication. This article was co-authored by
Hristo Nikolov, David Holdsworth, Graham Fraser, and Christopher Ellis.
iii
Acknowledgments
In this section, I would like to extend my gratitude to all those who have made the
completion of this work possible. I would like to acknowledge not only those who have
contributed directly to the science, but also those who have played an important role
leading up to the completion of this work.
Firstly, I would like to express my deepest gratitude to my supervisors Drs. Christopher
Ellis and Graham Fraser for their guidance and support. I have had the privilege to
benefit from two great mentors, one who has had the full experience of a successful
career and one who’s career is just taking off and thus has recently been through the
stages through which I am about to embark. I would like to thank them for giving
me the freedom to pursue my interests and for sharing their wisdom when I was in
need.
Secondly, I would like to acknowledge the members of my advisory committee, Drs. Jeffery
Dixon, Daniel Goldman and Stephen Sims whose advice and critical analyses of my
work throughout the completion of my doctoral research have played an integral role
in my development as a scientist.
I would like to extend a special thanks Stephanie Milkovich whose support and guid-
ance in the lab were invaluable to my progress. She was also involved in the data
collection for the animal work; and for that I am grateful. I would also like to thank
all lab members, past and present for their support and advice throughout my de-
gree. I am particularly grateful to Paulina Kowalewska whose insights in protocol
development and hours of troubleshooting were much appreciated.
I am also grateful to all the collaborators and co-authors involved in my project, es-
pecially Daniel Lorusso who taught me the secrets of microfluidics and Hristo Nikolov
who would 3D print anything I asked for.
I would like to thank NSERC and CIHR for the financial support of this work.
Finally I would like to acknowledge all of the friends and family who helped me
iv
get through this degree, especially my parents, Chuck and Teresa Sove´, and my
siblings Todd, Sean and Jessica Sove´ who were always available to provide emotional
support. A special thanks to my aunt and uncle, Madelyn and Shawn Porter who
have been my home-away-from-home here in London. I would like to express the
greatest appreciation to Nicole Drakos for her patience and understanding, insightful
conversations, help in the editing process and continued moral support.
v
Table of Contents
Abstract i
The Co-Authorship Statement iii
Acknowledgments iv
1 Understanding Oxygen Regulation in the Microcirculation 1
1.1 Oxygen-Dependent ATP Release from Red Blood Cells . . . . . . . . 4
1.2 Measuring Hemoglobin Oxygen Saturation . . . . . . . . . . . . . . . 8
1.3 Computational Modelling . . . . . . . . . . . . . . . . . . . . . . . . 11
1.3.1 Mathematical Models . . . . . . . . . . . . . . . . . . . . . . . 12
1.3.2 Finite Difference Method . . . . . . . . . . . . . . . . . . . . . 13
1.3.3 Finite Volume Method . . . . . . . . . . . . . . . . . . . . . . 14
1.3.4 Finite Element Method . . . . . . . . . . . . . . . . . . . . . . 15
1.3.5 Solution of Algebraic Equations . . . . . . . . . . . . . . . . . 17
1.3.6 Mathematical Modelling in This Thesis . . . . . . . . . . . . . 17
1.4 Microfluidic Device Fabrication Principles . . . . . . . . . . . . . . . 18
1.4.1 Material Considerations . . . . . . . . . . . . . . . . . . . . . 19
1.4.2 Fabrication Techniques . . . . . . . . . . . . . . . . . . . . . . 21
1.4.3 Bonding Techniques . . . . . . . . . . . . . . . . . . . . . . . 22
1.5 Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
2 Localized oxygen exchange platform for intravital video microscopy
investigations of microvascular oxygen regulation 32
2.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
2.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
2.2.1 Gas Chamber Design and Fabrication . . . . . . . . . . . . . . 34
2.2.2 Animal Preparation . . . . . . . . . . . . . . . . . . . . . . . . 36
2.2.3 Data Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
2.2.4 Mathematical Model of Tissue Oxygenation . . . . . . . . . . 36
2.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
2.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
3 A Computational Model of a Microfluidic Device to Measure the
Dynamics of Oxygen-Dependent ATP Release from Erythrocytes 53
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
vi
3.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
3.2.1 Overview of Model . . . . . . . . . . . . . . . . . . . . . . . . 56
3.2.2 Hemodynamic Module . . . . . . . . . . . . . . . . . . . . . . 57
3.2.3 Oxygen Transport Module . . . . . . . . . . . . . . . . . . . . 58
3.2.4 ATP Release Module . . . . . . . . . . . . . . . . . . . . . . . 59
3.2.5 ATP Transport Module . . . . . . . . . . . . . . . . . . . . . 60
3.2.6 Luminescence Module . . . . . . . . . . . . . . . . . . . . . . 60
3.2.7 Optics Module . . . . . . . . . . . . . . . . . . . . . . . . . . 61
3.2.8 Simulations . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
3.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
3.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
4 Finite Element Model of Oxygen Transport for Microfluidic Design 77
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77
4.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
4.2.1 Analytic Model . . . . . . . . . . . . . . . . . . . . . . . . . . 80
4.2.2 Computational Model . . . . . . . . . . . . . . . . . . . . . . 85
4.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88
4.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90
5 Using digital inpainting to estimate incident light intensity for the
calculation of red blood cell SO2 from microscopy images 105
5.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
5.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
5.2.1 Maximum Intensity Images . . . . . . . . . . . . . . . . . . . 108
5.2.2 Inpainting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
5.2.3 Oxygen Saturation Calculation . . . . . . . . . . . . . . . . . 113
5.2.4 Image Acquisition . . . . . . . . . . . . . . . . . . . . . . . . . 113
5.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 113
5.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 120
6 Microfluidic Device for the Rapid Oxygen Desaturation of Hemoglobin
in Red Blood Cells 128
6.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 128
6.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 130
6.2.1 Gas Exchange Chamber . . . . . . . . . . . . . . . . . . . . . 130
6.2.2 Microfluidic Device . . . . . . . . . . . . . . . . . . . . . . . . 132
6.2.3 Experimental Setup . . . . . . . . . . . . . . . . . . . . . . . . 133
6.2.4 RBC SO2 Measurement . . . . . . . . . . . . . . . . . . . . . 134
6.2.5 ATP Measurement . . . . . . . . . . . . . . . . . . . . . . . . 135
6.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 137
6.3.1 SO2 Measurements . . . . . . . . . . . . . . . . . . . . . . . . 137
6.3.2 ATP Measurements . . . . . . . . . . . . . . . . . . . . . . . . 141
6.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 142
vii
7 Final Summary 149
7.1 Summary of Results . . . . . . . . . . . . . . . . . . . . . . . . . . . 150
7.2 Future Directions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 154
7.3 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 157
Appendix 160
Curriculum Vitae 162
viii
List of Tables
Table 2.1 Tissue Oxygen Transport Model Parameters . . . . . . . . . 38
Table 3.1 ATP Release Experiment Model Parameters . . . . . . . . . 63
Table 3.2 Simulation Parameter Range . . . . . . . . . . . . . . . . . . 65
Table 4.1 Microfluidic Oxygen Transport Model Parameters . . . . . . 88
ix
List of Figures
Figure 1.1 Current understanding of O2-dependent ATP release from RBCs. 7
Figure 1.2 Extinction coefficients of hemoglobin in the visible range. . . 9
Figure 2.1 Three dimensional CAD model of gas chamber components. . 35
Figure 2.2 Intravital video microscopy experimental setup. . . . . . . . 37
Figure 2.3 Gas exchange window design. . . . . . . . . . . . . . . . . . . 39
Figure 2.4 Computational simulation predicting the extent of diffusion
between the five windows. . . . . . . . . . . . . . . . . . . . 40
Figure 2.5 Predicted oxygen distribution. . . . . . . . . . . . . . . . . . 41
Figure 2.6 Capillary SO2 in response to a step change in O2. . . . . . . 42
Figure 2.7 Distribution of RBC SO2 in response to three window O2 levels
(2%, 5% and 7%). . . . . . . . . . . . . . . . . . . . . . . . . 43
Figure 2.8 Predicted time-dependent changes in tissue O2. . . . . . . . . 44
Figure 2.9 Oxygen saturation and supply rate change in response to square
wave oxygen challenge. . . . . . . . . . . . . . . . . . . . . . 45
Figure 3.1 Diagram of a conceptual microfluidic device for measuring
ATP release dynamics . . . . . . . . . . . . . . . . . . . . . . 55
Figure 3.2 Simulation results for a typical set of parameters . . . . . . . 66
Figure 3.3 Effect of varying channel height . . . . . . . . . . . . . . . . 67
Figure 3.4 Effect of varying ATP release time . . . . . . . . . . . . . . . 68
Figure 3.5 Effect of varying flow rate . . . . . . . . . . . . . . . . . . . 69
Figure 3.6 Effect of varying ATP release rate . . . . . . . . . . . . . . . 70
Figure 3.7 Effect of ATP degradation by luciferin/luciferase . . . . . . . 71
Figure 3.8 Effect of the permeability of the exchange membrane . . . . 72
Figure 4.1 Device Design . . . . . . . . . . . . . . . . . . . . . . . . . . 80
Figure 4.2 Dimensionless Solution . . . . . . . . . . . . . . . . . . . . . 82
Figure 4.3 Dimensionless O2 Drop . . . . . . . . . . . . . . . . . . . . . 83
Figure 4.4 Dimensionless Drop Rate . . . . . . . . . . . . . . . . . . . . 84
Figure 4.5 Solution to the 3D model . . . . . . . . . . . . . . . . . . . . 89
Figure 4.6 Effect of RBC Channel Cross Sectional Area . . . . . . . . . 90
Figure 4.7 Effect of RBC Channel Aspect Ratio . . . . . . . . . . . . . 91
Figure 4.8 Simulation of RBC Channel Aspect Ratios . . . . . . . . . . 92
Figure 4.9 Effect of Exchange Window Length . . . . . . . . . . . . . . 93
Figure 4.10 Effect of Spin Coat Thickness . . . . . . . . . . . . . . . . . 94
Figure 4.11 Effect of Hematocrit . . . . . . . . . . . . . . . . . . . . . . . 95
x
Figure 4.12 1D Model Prediction of Geometric Parameters . . . . . . . . 95
Figure 4.13 Hemoglobin Binding Curve . . . . . . . . . . . . . . . . . . . 98
Figure 4.14 Simulation of Ideal Design . . . . . . . . . . . . . . . . . . . 99
Figure 5.1 Modified coherence direction of 40x in-vivo microscopy image
of capillary segments in rat skeletal muscle. . . . . . . . . . . 110
Figure 5.3 Example of pixel intensity variations of representative pixels
in a capillary and the tissue. . . . . . . . . . . . . . . . . . . 115
Figure 5.4 Microscopy image with a mask overlayed indicating the in-
painting domain for the error calculation. . . . . . . . . . . . 116
Figure 5.5 Error estimation for an example image. . . . . . . . . . . . . 117
Figure 5.6 Distribution of inpainting errors for an example image. . . . 118
Figure 5.7 Contour plot of the absolute errors in SO2 as a function of the
relative errors in I0, for three different SO2 values. . . . . . . 120
Figure 5.8 Example SO2 calculation for selected in-focus cells . . . . . . 121
Figure 6.1 Three dimensional CAD model of gas chamber components. . 131
Figure 6.2 Schematic of the microfluidic device with gas chamber interface.131
Figure 6.3 Schematic of the fabrication process. . . . . . . . . . . . . . . 133
Figure 6.4 Micrograph of the microfluidic device. . . . . . . . . . . . . . 134
Figure 6.5 Extinction coefficients of hemoglobin as a function of wave-
length. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136
Figure 6.6 Microscopy images of RBCs in microfluidic. . . . . . . . . . . 138
Figure 6.7 Optical density of red blood cells as a function of position
downstream in the microfluidic device. . . . . . . . . . . . . 139
Figure 6.8 Relationship between optical density ratio and SO2. . . . . . 140
Figure 6.9 SO2 as a function of position downstream in the microfluidic
device. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
Figure 6.10 ATP standard curve for EMCCD camera. . . . . . . . . . . . 141
xi
Chapter 1
Understanding Oxygen Regulation
in the Microcirculation
Oxygen (O2) is necessary for normal cell function, and due to diffusion limitations,
the circulatory system is a necessary means of delivering O2 to most cells throughout
the body. In order to meet physiological demands, our bodies must be able to adapt
to changes in metabolism as well as to perturbations in O2 supply. While O2 regula-
tion comprises a vast set of literature, this thesis is focused on O2 regulation at the
microvascular level, and thus this section will provide a broad overview of O2 regula-
tion at global scales as well as examples of proposed mechanisms at the microvascular
level. For a review of vascular control mechanisms in the microcirculation, see the
2005 review by Segal [1].
Most mechanisms control O2 supply by means of blood flow modulation; an increase
in blood flow leads to an increase in O2 supply. Blood flow can be modulated globally
by increasing heart rate or contractility, or locally by controlling the vascular tone of
arterioles. The latter is accomplished by contraction/relaxation of vascular smooth
muscle. Modulation of heart rate can elicit a change in systemic flow rate and pres-
sure, though this form of O2 supply control can be inefficient since blood flow would
be increased everywhere, even to regions that do not require more O2. It is more
1
2efficient to simply redirect flow, rather than increase flow rate everywhere.
The myogenic response provides an example of vascular tone modulation. In this
mechanism, arterioles respond to local increases in blood pressure. The increased
blood pressure causes the smooth muscle in the blood vessel walls to stretch, result-
ing in the contraction of the muscle.
For efficient regulation, O2 supply (blood flow) must be linked to O2 demand (rate of
O2 consumption) [2–4]. There has been evidence of O2 supply being linked directly
to the presence/absence of O2 as well. Several studies report that the presence of O2
leads to vasoconstriction [5–9], while the absence leads to vasodilation [10–12]. The
location of the O2 sensor remains unknown [13]. Some researchers have suggested
that an O2 sensor lies within the blood vessels of the microcirculation [10, 14–21].
Others have proposed the putative sensor is located in the tissue surrounding the
vessels [22, 23]. There have also been suggestions that a sensor for O2 lies within the
RBC.
As the carrier of O2, the RBC would be a logical choice for the sensor. For instance,
in a study of hypoxia, Stein et al. suggested that SO2 is a more critical determinant
of O2 supply to tissue than oxygen tension (PO2) [24]. Since PO2 affects the diffusion
of oxygen from the blood to the tissue, and the RBCs are the only component of the
system that is affected by SO2 (through their binding to hemoglobin); this suggests
that the mechanism responsible for sensing oxygen likely occurs within the RBC.
There have been three mechanisms proposed where the O2 sensor is located in the
RBC.
3One of the proposed RBC-mediated mechanisms is through the release of S-nitrothiol
(SNO) from hemoglobin [25]. SNO has been shown to be released from the hemoglobin
in RBCs in response to the conformational change associated with the deoxygenation
of hemoglobin. SNO is suggested to be a vasoactive molecule that elicits vasodilation
in arterioles, increasing blood flow to downstream capillaries. Despite the evidence
supporting the role of SNO as a mechanism for O2 regulation, there are numerous
studies refuting this as a viable mechanism [26–28].
Another proposed mechanism suggests that fully deoxygenated hemoglobin acts as a
nitrite reductase. In this mechanism, nitrite is converted to nitric oxide, which plays
an important role in vasodilation [26, 29, 30]. Due to the slow dynamics associated
with the reduction of nitrite, this mechanism likely lacks the temporal resolution re-
quired to tightly regulate O2 supply [31].
Finally, ATP has been shown to be released from RBCs in response to low O2 [32]
and other stimuli [32–34]. The ATP released into the plasma of blood vessels binds
to receptors on the membrane of the endothelial cells lining the vessel lumen [35].
This is thought to trigger a conducted signal through gap junctions in the endothe-
lium, leading to vasodilation of upstream arterioles [36, 37]. Of the three mechanisms
discussed above, this third mechanism is the only mechanism capable of triggering
a conducted vasodilatory response, enabling the capillaries, the primary site of O2
exchange, to contribute to regulation of O2 [31].
The main goal of this thesis is to develop tools to study O2-dependent ATP release
in RBCs. Evidence for O2-dependent ATP release will be presented in Section 1.1,
followed by an introduction to some important methodology that can be applied
4to the study of the local regulation of O2 distribution. In particular, fundamental
principles of hemoglobin SO2 measurements (Section 1.2), the basics of computational
modelling (Section 1.3), and an introduction into microfluidics (Section 1.4) will be
discussed. Finally, the outline of this thesis will be presented in Section 1.5.
1.1 Oxygen-Dependent ATP Release from Red Blood
Cells
In 1919, August Krogh proposed a mathematical model of O2 delivery to tissue [38].
His idealized model assumed that each capillary in a tissue supplied a cylinder of
tissue surrounding it. In his model, all of O2 delivery was assumed to happen at the
level of capillaries, thus each capillary had the same entrance O2 concentration. The
model suggested that the size of the tissue cylinder is dictated by the concentration
of O2 in the capillaries and the O2 consumption rate of tissue. Based on this, it was
proposed that increasing capillary density could compensate for increased metabolic
demand.
Since Krogh’s work, many researchers have been searching for mechanisms for cap-
illary recruitment. However, this view that capillaries have uniform O2 content is
over-simplistic; in 1970, Dulling and Berne demonstrated a substantial loss of O2 in
artierioles [39]. Various animal models and tissue preparations have confirmed this
finding [40–42]. There is also evidence for O2 exchange from arterioles to capillaries
[18]. These findings suggest that there is a diffusional loss of O2 in arterioles, leading
to a radial gradient across the arteriole where O2 content of RBCs nearest to the wall
would be lower than those travelling near the centreline [43, 44], since O2 would be
lost through the wall. At asymmetric bifurcations, slower flowing RBCs near the wall
5would flow down the low-flow branch of the bifurcation, leading to a heterogeneous
distribution of O2. This evidence lead to a contradiction of the original assumptions
in Krogh’s model. Due to the complexity of O2 distribution in the circulation, a more
locally sensitive mechanism is required to regulate the distribution of O2 to meet
metabolic demands. As discussed in the previous section, one potential mechanism
is the O2-dependent release of ATP from RBCs.
In the late 1940s, the optical detection and measurement of ATP was made possible
following the finding that firefly lantern extract (known today as firefly luciferin and
luciferase) luminesces in the presence of ATP [45]. This assay was further refined by
Strehler and McElroy in 1957 [46]. Since then, many researchers have used this assay
to investigate the presence of extracellular ATP in various tissues and organs [47–49].
For example, Forrester and Lind detected ATP in human blood plasma [48]; this was
the first hint at ATP release from RBCs.
Oxygen-dependent ATP release from RBCs was first measured by Bergfeld and Forester
in 1992 [32]. They used the firefly luciferase assay to measure a significant increase
in plasma ATP concentrations following exposure to low O2 and high pH. In 1995,
Ellsworth et al. were able to isolate the two effects and measured increased plasma
ATP concentrations in response to O2 with a fixed pH [33].
It was further shown that the injection of ATP into the vascular lumen leads to a dose-
dependent vasodilatory response [50]. This is proposed to be triggered by the binding
of ATP to the purinurgic receptor, P2Y2, on the inner luminal wall [35, 37, 51–53]. The
purinurgic activation results in the synthesis and release of vasodilators, such as nitric
oxide (NO) and prostacyclin (PGI2), which act to relax the vascular smooth muscle in
6arterioles [54]. This cascade also activates calcium-sensitive potassium channels, lead-
ing to hyperpolarization of endothelial and/or smooth muscle cells [55–57]; smooth
muscle hyperpolarization leads to dialtion [58, 59]. Hyperpolarization can be con-
ducted through gap junctions to adjacent endothelial/smooth muscle cells, leading
to a conducted vasodilatory response [55–57]. Further evidence for ATP release has
shown that decreasing the O2 content of blood vessels in the absence of RBCs elicits
no vascular response [34].
Jagger et al. showed a linear relationship between the steady-state RBC SO2 and
the amount of ATP released [60]. This lead to the hypothesis that ATP release was
related to the conformational change in hemoglobin due to its change in saturation.
This hypothesis was supported by using carbon monoxide to keep hemoglobin in its
saturated conformation and varying the O2 content of the RBCs. This was further
confirmed by several human studies [61–63].
The ATP release mechanism for O2 regulation was also supported by Ghonaim et
al. in vivo by manipulating the surface O2 levels of a rat skeletal muscle preparation
using a gas exchange chamber [64]. They showed that a change in tissue O2 leads to
a change in supply rate. ATP release has also been shown to be altered in diseases
such as prediabetes [65, 66], type II diabetes [67] and sepsis [68].
In the current view of ATP release, ATP is released from RBCs into capillaries under
local hypoxic conditions. The ATP released into the plasma is then able to bind to
receptors on the endothelium of the capillary which RBCs are in contact with. This
triggers a conducted vasodilatory response upstream to feeding arterioles that can
then dilate to increase RBC flow, and hence O2 supply. Figure 1.1 shows the pro-
7posed mechanism for a single RBC signalling to capillary endothelial cells. Since the
RBCs (sensors) are moving through the capillaries, the time-dependence (dynamics)
of ATP release dictates the ability of the regulatory system to accurately report the
location of low O2; if ATP is released too late, the RBC will be far downstream from
the site of low O2.
O2
ATP
Figure 1.1: Current understanding of O2-dependent ATP release from RBCs. Anatomic composite
image from a single 40X microscopy video frame (opacity 64%) superimposed on a functional im-
age (left). The video frame was processed as optical density such that low values (black) represent
background and high values (white) represent high absorbers, such as RBCs. The functional image
consists of the minimum pixel intensity over time; in the functional image areas with passing cells ap-
pear dark. The white arrow indicates the direction of RBC flow. (Center) Schematic representation
of a single RBC in close contact with the capillary endothelium. (Right) Schematic representation
of the ATP release mechanism in response to low O2. Following RBC desaturation, ATP is re-
lease through pannexin 1 channels in the RBC membrane. ATP in the vessel lumen either binds to
endothelial P2Y2 receptors or is degraded by ectoATPases. P2Y2 binding activates Ca
2+-sensitive
potassium channels, resulting in hyperpolarization of the endothelial cell, which can be conducted
through gap junctions. This figure was adapted from [69].
In summary, ATP release seems to be an important mechanism in the regulation
of O2, however, its dynamics have not yet been fully elucidated. The main goal
8of this thesis is to develop methodology to explore the dynamics of O2-dependent
ATP release. Since this mechanism is dependent on RBC SO2, the methodology
developed in this thesis involves perturbing SO2. Therefore quantifying the degree
of desaturation is imperative. Section 1.2 outlines the methodology behind optical
measurements of SO2 from microscopy images.
1.2 Measuring Hemoglobin Oxygen Saturation
The measurement of hemoglobin oxygen saturation (SO2) is made possible by the
spectral properties of hemoglobin; hemoglobin absorbs light differently based on the
binding of oxygen. Figure 1.2 shows the hemoglobin absorption spectrum for fully
saturated- and fully desaturated-hemoglobin in the visible light spectrum; data in
this figure were tabulated by Scott Prahl [70]. The quantity shown in this figure
is called the molar extinction coefficient, which is a measure of the amount of light
absorbed per concentration of hemoglobin per path length. It is specifically defined
in the relationship between incident and transmitted light:
I = I010
−ε(λ)cx, (1.1)
where I0 is the incident light intensity, I is the intensity of light transmitted through
the hemoglobin sample, c is the concentration of hemoglobin and x is the path length.
The extinction coefficient of hemoglobin at wavelength λ is given by ε(λ). The argu-
ment of the exponential is known as optical density OD ≡ εcx and can be calculated
by
9Figure 1.2: Extinction coefficient for fully oxygen saturated- (red) and fully oxygen desaturated-
(blue) hemoglobin as a function of wavelength in the visible range.
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OD = log10
(
I0
I
)
. (1.2)
Expanding the optical density expression, OD = εcx, the optical density of red bloods
cells can be written as
OD(λ) =
(
εHbO2 (λ)SO2 + εHb(λ)(1− SO2)
)
cx, (1.3)
where SO2 is hemoglobin oxygen saturation and εHbO2 and εHb are the extinction
coefficients for fully saturated- and fully desaturated- hemoglobin, respectively.
Given the optical density of RBCs at two wavelengths, λ1 and λ2 we can determine
SO2 by taking the ratio of the optical densities and solving for SO2.
SO2 =
b1 − b2R
a2R− a1 (1.4a)
R =
OD(λ1)
OD(λ2)
(1.4b)
ai = εHbO2 (λi)− εHb(λi) (1.4c)
bi = εHb(λi) (1.4d)
where the constants a1, a2, b1 and b2 are usually obtained by calibration with RBCs
of known SO2. If the second wavelength, λ2, is chosen to be O2-independent, also
called isosbestic, the relationship between optical ratio and SO2 becomes linear [71].
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The intensity value, I, can be measured from the pixel intensity in an image. The
incident light, I0, however, is not directly measurable. This value is often approxi-
mated using video data to measure the light intensity of the plasma gaps between
the RBCs as they travel single file through the capillaries [72]. As the RBCs move
out of the way, the plasma intensity gives the intensity of the pixels behind the RBC.
This can be accomplished algorithmically by calculating the maximum intensity at
each pixel over a specified number of frames, since RBCs absorb more light, and thus
have lower intensity values than the plasma. In Japee et al., the maximum intensity
minus three standard deviations is used as the value for I0. In more recent studies, the
maximum value is used since low-noise digital cameras are used to acquire the images.
Overall, RBC SO2 provides a good measure of tissue oxygenation [24] and is a in-
valuable tool in the study of O2 regulation. However, there are scenarios in which
we would like to determine concentrations of O2 that may be difficult or impossible
to measure. Computational modelling provides a useful way to predict the spatial
distribution of oxygen and other physical quantities based on mathematical models.
Section 1.3 presents a simplified overview of computational modelling based on con-
servation laws and some useful numerical techniques that can be used to solve the
governing partial differential equations.
1.3 Computational Modelling
Computational modelling consists of using computers to simulate the behaviour of
complex processes based on a mathematical representation; they can be used to sim-
ulate physiological scenarios to facilitate the understanding of the system without the
time or cost associated with experiments. For instance, to study the effect of capil-
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lary perfusion loss on tissue oxygenation, Fraser et al. used a computational model
of O2 transport to predict tissue oxygenation where perfusion loss was simulated by
systematically removing capillaries from the simulation [73]. This approach is more
feasible than using an experimental model where more variability is introduced.
Various types of mathematical models can be constructed based on the goals and
needs of the study. The mathematical models in this thesis are constructed based
on the physical principle of conservation. In conservation models, the dependent
variables are often functions of space. These models can also be either dynamic
(time-dependent), or steady-state (constant in time). This section outlines how these
types of mathematical models are formulated followed by several strategies for solving
the governing equations on a computer.
1.3.1 Mathematical Models
Many mathematical models are formulated as a (set of) partial differential equation(s)
(PDE(s)) that describe the how a physical phenomenon varies through space and/or
evolves over time. These PDEs are generally formulated from conservation laws, such
as the conservation of mass. Once the set of PDEs are determined, a set of initial
and boundary conditions are required to obtain a unique solution. Physical models
based on conservation principles result in PDEs of the following form
∂u
∂t
+ ~v · ∇u = ∇ · (D∇u) + s, (1.5)
where u is the quantity of interest. The first term on the left hand side of the PDE
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represents the evolution of u over time and the second term represents spatial trans-
lation of u at the velocity, ~v. On the right hand side, the first term represents the
diffusion of u where D dictates the extent of diffusion and the second term represent
sources/sinks of u, where s is the strength of the source/sink. For example, in the
context of mass transport, u would be solute concentration. The terms of the PDE
from left to right would represent temporal evolution, convection, diffusion, and se-
cretion/consumption, respectively.
To define the system uniquely, a set of initial/boundary conditions must be defined.
Initial conditions define the system at the beginning of the time of interest at every
point in space and the boundary conditions define the system at the boundaries of
the domain for all time after t = 0. Initial and boundary conditions are generally
given in terms of the dependent variable or its derivatives.
In general, PDEs cannot be solved exactly; in order to obtain a solution, a numerical
approximation must be made. There are three common classes of approximation
techniques for PDEs: (1) the finite difference method (FDM), (2) the finite volume
method (FVM) and (3) the finite element method (FEM). Each discretization method,
solves for the function of interest, u(x, y, z, t), at discrete points in time and space,
uni (where n is the time index and i is the spatial index).
1.3.2 Finite Difference Method
FDM approximates the derivatives in the PDE using a difference approximation. In
order to obtain an approximation of the partial derivatives, the time and spatial
domains need to be discretized into a grid such that the grid lines lie along the
coordinate directions. Continuous functions can then be expressed as a set of discrete
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values organized into a tabular structure (e.g. f(x, y, z, t) ≈ fni,j,k). One example of a
finite difference approximation is called Euler’s method and is defined as follows
∂u
∂t
≈ u
n+1
i,j,k − uni,j,k
∆tn
, (1.6)
where ∆tn is the nth temporal step size. This FDM approximation is first order,
meaning the error is linearly proportional to ∆t. More accurate schemes can be de-
rived using higher-order Taylor-series expansions.
Using these difference approximations, we can write the entire differential equation
in terms of discrete variables. This procedure transforms the PDE into a system of
algebraic equations which can then be solved computationally.
The finite difference method is generally quite simple to implement and can be used to
discretize even the most complex PDEs. The main disadvantage to the FDM is that
it is not straightforward to implement for complex geometries. For more complicated
geometries, the finite difference method is often used to approximate the temporal
derivatives and the rest of the PDE can be discretized using either FVM or FEM.
1.3.3 Finite Volume Method
FVM uses a discrete approximation of the integral form of the conservation law.
Equation 1.5 can be rewritten as the following integral equation
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∫
∂Ω
nˆ · (~vu−D∇u) dA =
∫
Ω
sdV, (1.7)
where Ω is the spatial domain and ∂Ω is the boundary; nˆ is the unit normal to the
boundary.
The integrals are approximated by a discrete summation. One example would be the
midpoint rule on a cubic volume:
∫ 1
0
∫ 1
0
∫ 1
0
f(x, y, z)dxdydz ≈ f
(xi
2
,
yi
2
,
zi
2
)
∆x3i , (1.8)
where i is the volume’s index and ∆xi are the side lengths of the cubic volume
elements. This quadrature rule is first-order accurate; more accurate schemes can be
derived. Once each integral in the equation is approximated, a system of algebraic
equations are obtained and can be solved using a computer.
1.3.4 Finite Element Method
FEM uses variational calculus to minimize the residual, R, of the spatial PDE. The
residual of the PDE presented in Equation 1.5 is given by
R(u˜) = ~v · ∇u˜−∇ · (D∇u˜)− s, (1.9)
for some function u˜. If the residual of the PDE is zero then u = u˜ is the solution.
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The fundamental theorem of variation calculus states that if
∫
Ω
v(~x)w(~x)dV = 0, (1.10)
for all w(~x), then v(~x) = 0 for all ~x in Ω. This theorem can be used to constrain the
residual to zero. Rewriting the theorem using the residual we find:
∫
Ω
w(~x) (~v · ∇u−∇ · (D∇u)− s) dV = 0, (1.11)
The dependent variable, u, is then chosen to be
u(~x) =
N∑
i
uiφi, (1.12)
where φi is the i
th shape function of the spatial discretization. The shape function has
the properties that φi = 1 at the i
th node of the spatial discretization and 0 at every
other node and φi varies according to a polynomial along the adjacent elements (for
example φi can be piecewise linear). This choice of u results in an algebraic equation
with N unknowns; the system is closed with the choice of N different w(~x) functions.
One example is the Galerkin method which chooses wj = φj [74].
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1.3.5 Solution of Algebraic Equations
After obtaining the system of equations, it must be solved to get the approximate
solution to the PDE. There are many methods to solve linear systems of equations,
most of them rely on an iterative procedure. The solver should be chosen based on the
size and shape of the resulting matrix. For example, if the matrix is symmetric and
positive definite, the conjugate gradient method solves the system in O(n) operations.
The generalized minimal residual (GMRES) method is a more robust linear solver
that works for any matrix [75]. With GMRES, speed is sacrificed in order to handle
a more general problem.
1.3.6 Mathematical Modelling in This Thesis
This thesis uses numerous computational models and numerical techniques in the
development of tools to study microvascular O2 regulation. In particular, we use
the finite difference and finite element methods. The finite difference method is the
simplest to implement for simple geometries; for more complex geometries, the finite
element method is used.
In Chapter 2, an in vivo microfluidic device is developed to perturb the local O2
levels in a rat skeletal muscle preparation. A time-dependent computational model
of O2 transport is used to estimate how far into the muscle the perturbations extend;
this model is discretized using the finite difference method and parallelized to reduce
computation time. Chapters 3, 4 and 6 present the design, development, fabrication
and validation of an in vitro microfluidic device designed to measure the release time
of ATP from RBC in response to low O2. In Chapter 3, computational modelling is
used to simulate the in vitro experiment to determine if it is theoretically feasible;
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these PDEs are discretized using the finite difference method. In Chapter 4, a 3D
model of the O2 transport through the microfluidic device is used to optimize its
geometry. The finite element method was used for the discretization to facilitate the
use of arbitrarily complex geometries. Finally, Chapter 5 presents an image analysis
method to estimate RBC SO2. Though no physical models are used, partial differ-
ential equations are used to estimate the incident light intensity; these equations are
discretized using the finite difference method.
In summary, mathematical modelling is a useful tool for predicting the transport of
O2 in systems used to study microvascular O2 regulation, both in vivo and in vitro.
Computational modelling, however, does not address design considerations related to
the fabrication of microfluidic devices. Section 1.4 presents a selective overview of
microfluidic fabrication techniques.
1.4 Microfluidic Device Fabrication Principles
Microfluidics is a rapidly emerging field with a wide range of scientific applications.
It is defined as the manipulation of fluids in channels having characteristic lengths on
the order of tens to hundreds of micrometers [76]. Microfluidics were first developed
in the 1970s using techniques from the well-established field of microelectronics [77].
In the 1990s, microfluidics began to rapidly grow as research expanded into the use of
new classes of materials, notably polymers [76]. Applications include rapid analysis
of bodily fluids (e.g. blood) [78], point of care diagnosis [79], analysis of environmen-
tal contaminants [80], fluid dynamics [81], in vivo drug delivery [82] and biomimetic
systems [83].
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Microfluidics have several advantages over many other experimental methods since
they have lower reagent consumption due to the small volumes used and allow for
higher throughput. Further, with the advances in polymer fabrication techniques,
microfluidic devices have low manufacturing costs and their fabrication process has
become accessible to general scientists [84]. This allows for the fabrication of spe-
cialized microfluidic devices with relative ease, therefore, microfluidic devices can be
rapidly prototyped, accelerating research progress.
The objective of this section is to outline the basic principles of common fabrication
techniques. Section 1.4.1 will begin with considerations with regards to the materials
used in the fabrication of microfluidic device. Next, Section 1.4.2 will describe several
common techniques used to fabricate components used in the production. Finally,
select popular bonding techniques will be discussed in Section 1.4.3.
1.4.1 Material Considerations
Early microfluidic devices were primarily fabricated in glass or silicon using pho-
tolithography and chemical etching [85, 86]. Glass has the benefit of being optically
transparent, electrically insulating, thermally conducting, rigid and resistant to most
organic solvents. Silicon has similar benefits to glass, though it is optically opaque
and is electrically conductible. During the etching process, silicon is able to main-
tain vertical side walls, whereas channels etched in glass result in curved side walls
[87]. Additionally, the fabrication process for both materials requires a clean room,
dangerous chemicals in the etching process and high pressures or temperatures in the
bonding process [85, 88]. Thus, the manufacturing process for microfluidic devices
fabricated in glass or silicon generally require a special facility and often have large
costs.
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More recently, polymers have become a popular class of materials to use in the fab-
rication of microfluidic device [76]. Polymers can be classified into three categories;
(1) thermosets, (2) thermoplastics and (3) elastomers.
Thermosets are polymers that become cross-linked and harden when heated or irra-
diated. After hardening, thermosets cannot be reshaped, thus they are stable at high
temperatures. Further, they are resistant to most solvents and optically transparent.
Their high strength makes them ideal for fabricating channels with high aspect ratios.
One thermoset used in microfluidics is the UV-sensitive epoxy SU-8 [89]. Though,
due to the high cost of thermosets, they have limited applications in microfluidics [90].
Thermoplastics are solid polymers that, when heated become soft and moldable.
Common thermoplastics include poly(methylmethacrylate) (PMMA), polycarbonate,
polystyrene, polyvinyl chloride (PVC) and polyethylene terephthalate (PET) [91].
Thermoplastics can be reshaped multiple times, which allows for a flexible manufac-
turing process. Like thermosets, they are typically rigid and impermeable to gases,
though they are incompatible with most organic solvents (e.g. ketones and hydro-
carbons). Due to the high temperatures required, thermoplastics tend to have more
applications in commercial manufacturing of microfluidics than in an academic set-
ting [90].
Elastomers are polymers that consist of entangled cross-linked polymer chains. The
entanglement gives elastomers their elastic property. Due to their porous structure,
elastomers tend to be permeable to gases and other small molecules. This makes
elastomers incompatible with many solvents, since small molecules dissolved in the
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solvent can be adsorbed into the elastomer [92]. However, their elasticity allows
them to be used as valves in microfluidic devices [93]. The most common elastomer
in microfluidics is poly(dimethyl siloxane) (PDMS) [76]. PDMS is inexpensive and
optically transparent.
1.4.2 Fabrication Techniques
In the fabrication of microfluidic channels, a cavity is made in the material to form
a channel, the channel is then sealed with a flat piece of material by some bonding
process. The process by which the channel is formed depends on the material used.
For glass and silicon, the most common method for forming the channel is using
photolithography to etch the cavity into the material. The glass or silicon is first
cleaned thoroughly, then a photoresist is spin coated onto the substrate. Following
this, a photomask is applied and the substrate with photoresist is exposed to light.
The glass/silicon is then treated with a chemical to etch the material where the pho-
toresist is absent. The depth of the channel is dictated by the length of exposure.
After the etching is done, the remaining photoresist is removed. This process yields
rectangular channels for silicon and rounded channels for glass, where the curvature
depends on the chemical used for etching and depth.
For polymers, the most common method is replica molding, where the polymer is
cast onto a master containing a positive resist of the channel. After the polymer is
cured, the replica is removed from the mold and is ready to be sealed. The master
molds are usually fabricated using photolithography [84] or micro-machining [93].
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Thin membranes are often required for applications in microfluidics; for elastomers,
this is generally formed by way of spin coating. The spin coating process allows for
a thin, even layer of the polymer to be made. The thickness of the layer is controlled
by the angular frequency of the rotating plate. The time for spin coating must be
carefully chosen; the time must be sufficient for the process to reach steady state, but
not so long that evaporation occurs.
1.4.3 Bonding Techniques
Once the individual components are fabricated, they are bonded together to form
the final microfluidic device. This section will outline popular bonding techniques
for PDMS. For components made from glass or silicon, fusion or anodic bonding can
be used. For a complete review, see [94]. Four methods will be discussed: oxygen
plasma, varying curing ratio, partial curing and corona treatment.
In the oxygen plasma method, the contact surfaces of two PDMS components are
brought into conformal contact after being treated with oxygen plasma. This process
oxidizes the surfaces to allow the PDMS structures to be irreversibly bonded [84].
This method results in hydrophilic surfaces, which have the benefit of allowing easier
fluid filling, though this benefit subsides over time [95]. The main drawbacks of this
method are that it is expensive and must be done in an evacuated chamber in clean-
room conditions.
In the varying curing agent method, different ratios of prepolymer and cross-linker
are used to create the bond. In this method, one of the components is made with
more prepolymer than cross-linker, while the second component will be made with
more cross-linker [96]. This approach is advantageous since it does not require ad-
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ditional surface treatment, however, it may not be suitable for all applications since
the material properties will vary throughout the PDMS [95].
In the partial curing method, a fully cured component is put into contact with a
partially cured component, resulting in an irreversible bond. This method has been
shown to be effective and inexpensive for making multilayered devices [95].
In the corona discharge method, a handheld device generates a high electric field on
the surface of fully cured PDMS, causing surface oxidization [97]. This process can
be done at room temperature and pressure, without the need of a vacuum system
[95].
1.5 Purpose
The objective of this thesis is to develop methodology that can be used to study the
complex regulatory mechanisms involved in the regulation of O2 distribution. Overall,
it presents the development of two microfluidic devices. The first device, presented
in Chapter 2 is an in vivo device that can be used to perturb the local O2 content
of specific networks of capillaries in order to interrogate the regulatory mechanisms
of the microvasculature. The next two chapters detail mathematical models used
to design an in vitro device that can probe the O2-dependent ATP release from
RBCs in isolation. Specifically, Chapter 3 presents a theoretical model of an in
vitro experiment designed to measure the temporal behaviour of O2-dependent ATP
release from RBCs. Chapter 4 uses a finite element model of O2 transport through
the proposed device in order to optimize the geometric design. To assess the ability
of this device to desaturate RBCs, current in vivo methodology for measuring SO2
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needs to be extended in order to apply to the in vitro images; Chapter 5 details an
image processing algorithm to we developed to do this. Chapter 6 presents the actual
fabrication of this in vitro microfluidic device, and verifies its ability to deoxygenate
RBCs. Finally, Chapter 7 discusses the implications of the findings of this work and
potential avenues to be pursued in the future.
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Chapter 2
Localized oxygen exchange
platform for intravital video
microscopy investigations of
microvascular oxygen regulation
2.1 Introduction
Oxygen (O2) regulation is a critical physiological function where precise regulatory control
is required to ensure the metabolic demands of the tissues of the body are met. In order for
such a level of control to be possible, there must be various mechanisms in place to sense
O2 demand and correspondingly adjust O2 supply.
Numerous studies have confirmed that the presence/absence of O2 in the microcirculation
results in a vasoactive response such that high levels of O2 result in vasoconstriction [1–5]
and low levels of O2 result in vasodilation [6–8]. These findings allude to the existence of
an O2 sensor, the location of which remains unclear [9]. Potential locations include the red
blood cell (RBC), arteriolar smooth muscle, arteriolar endothelium and even extra-vascular
cells; see [9] for an in-depth review.
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There has been substantial evidence pointing to the RBC as the sensor for O2 in the mi-
crocirculation; see review by Ellsworth et al. [10]. One potential mechanism that has been
proposed is the O2-dependent release of ATP from RBCs. In this mechanism, ATP is re-
leased from RBCs in response to decreased oxygen tension leading to increased plasma ATP
[11, 12]. The intra-luminal ATP then binds to P2Y2 receptors on the blood vessel endothe-
lium triggering an upstream vasodilatory response [13–16]. Several pathological conditions
have been associated with an impaired ability to release ATP, such as sepsis [17] and type
II diabetes [18–20], potentially affecting the ability to regulate oxygen.
Various studies have used microscopy in conjunction with methods to alter the tissue oxy-
genation to interrogate the regulatory system [4, 5, 8]. For instance, suffusion solutions with
varying levels of O2 have been used to control O2 in several tissue preparations to study
the regulatory response [5, 8]. In previous studies, we used intravital video microscopy that
combines a gas exchange platform with computer controlled gas flow meters to manipu-
late the gas composition at the surface of rat extensor digitorum longus (EDL) muscle to
study the response of the microcirculation to a range of O2 concentrations [21–23]. In these
studies, the entire surface of the muscle was affected by the change in O2. While these
approaches were able to elicit vasodilatory responses, more localized changes in O2 could
potentially reveal information leading to the location of the O2 sensor.
More recently, a localized micro-delivery system was developed that was capable of limiting
the change in RBC oxygen saturation (SO2) to a circular area of approximately 175 µm in
diameter [24], however, changes in supply rate were not reported [24]. This finding was sup-
ported by a mathematical model of the regulatory system that suggests that the signal for
vasodilation is additive and depends on the number of capillaries that are stimulated [25].
A later study used a larger exchange window (1 mm long by 0.1 mm wide) to manipulate
the RBC SO2 of a much larger area; this larger exchange window elicited a flow response
[26]. This work further supports the idea that the vasodilatory signal is additive.
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The work in Ghonaim et al. [26] showed promising results which were consistent with the
proposed ATP release mechanism, however, there were some limitations for studying O2
regulatory mechanisms. First, stimulating multiple microvascular units at the same time
potentially affects multiple feeding arterioles. Additionally, the setup in Ghonaim et al.
could only resolve capillaries that were less than 60 µm from the surface; one challenge as-
sociated with using gas exchange chambers with intravital microscopy is that the chamber
must be placed in between the objective and the muscle, reducing the effective focal depth.
This impedes the ability to focus on structures deeper in the tissue.
This study presents a refined gas exchange design that is modular and capable of changing
local tissue O2 tension in small regions affecting single microvascular units. One potential
benefit of such a device is to determine if stimulation of a single microvascular unit is
sufficient to elicit a flow response. By making the design modular, the device can be easily
adjusted to suit different needs. For example, the shape and size of the exchange surfaces
can easily be changed. This design also aims to maximize the focal plane in order to view
structures deeper in the tissue as well as allowing for viewing of adjacent regions in the
tissue. In addition, we used a GPU accelerated computational model of oxygen transport
to estimate O2 content in the tissue and the temporal affects of changing O2 in the chamber.
Overall, we developed a modular gas exchange device for studying oxygen regulation in the
microcirculation.
2.2 Methods
2.2.1 Gas Chamber Design and Fabrication
The gas exchange chamber was comprised of a microscope stage insert, a gasket to form the
side walls of the channel and a platform for the inlet and outlet of the channel (see Figure
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6.1). The bottom of the channel was closed by a replaceable glass slide. The top of the chan-
nel was closed by a custom, laser-cut glass slide with five windows for gas exchange using a
process described in [27]; the windows were sealed with a thin, gas-permeable, membrane.
The components were assembled together using vacuum grease to ensure no gas leakage.
Stage 
Insert
Inlet and  
Outlet
Gas Channel  
Gasket
Figure 2.1: Three dimensional CAD model of gas chamber components. Inlet/outlet mount
and stage insert were 3D printed. The gas channel gasket was made out polymethyl-methacrylate
(PMMA). The gas channel is sealed on the bottom with a glass cover slide and on the top with a
laser-cut glass cover slide.
The stage insert and platform for the inlet and outlet were designed in FreeCAD and
3D printed. The gasket was fabricated by hand cutting 100-µm sheets of polymethyl-
methacrylate (PMMA) to the desired shape. The gas-permeable membrane was fabricated
in PDMS using a spin-coating technique similar to [28]. PDMS (Sylgard 184, Dow Corning
Corporation) in a 10:1 prepolymer to cross-linker ratio by weight was spin-coated at 1700
rpm for 30 seconds; resulting membranes were approximately 45 µm in thickness.
Gas composition (O2, CO2 and N2) was controlled using computer controlled mass flow
meters. Gas temperature was maintained at 37 °C.
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2.2.2 Animal Preparation
Male Sprague-Dawley (150-200g) rats were anesthetized with 65 mg per kg of body weight
of pentobarbital sodium by intraperitonial injection. Following injection, the animals were
tracheotomized for ventilation as previously described [20, 29]. Animals were mechanically
ventilated with 30% oxygen and balance nitrogen while their inspired O2, heart rate, and
blood pressure levels were continuously recorded as described in [20]. The Extensor dig-
itorum longus (EDL) muscle of the hind limb was prepared for microscopy as described
in [30]; this preparation was based on that by Tyml and Budreau [31]. The muscle was
extended on the microscope stage using suture attached to the edge of the muscle. The
muscle was then covered with oxygen-impermeable Saran Wrap and a glass cover slip to
isolate it from the room oxygen conditions. The tissue was trans-illuminated with a 75
W xenon lamp (Olympus U-LH75XEAPO) using an Olympus IX-81 inverted microscope
equipped with 10X (Olympus U Plan S-APO; 0.4 NA) and 20X (Olympus U Plan LWD;
0.45 NA) objectives. The corresponding images were captured using the dual video camera
system previously described in [20]. The experiments used in this study were approved by
the University of Western Ontario’s Animal Care and Use Committee (see Appendix A).
2.2.3 Data Analysis
Intravital video microscopy images were acquired at 21 frames per second at two wave-
lengths, 438 nm and 450 nm using a beam splitter. Images were analyzed oﬄine using
software developed in MATLAB (Mathworks) to quantify SO2 and hemodynamics as pre-
viously described [30, 32–34].
2.2.4 Mathematical Model of Tissue Oxygenation
A mathematical model of tissue oxygenation is used to determine the extent of oxygen
diffusion in the tissue from the gas exchange chamber. Tissue oxygenation was simulated in
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Figure 2.2: Intravital video microscopy experimental setup. This figure shows the experimental
setup for an intravital experiment to allow for oxygen exchange to a localized area of tissue. In this
setup, the muscle is extended over the gas exchange window and covered in gas-impermeable saran
wrap to isolate the muscle from the surrounding environment.
3D over time. Tissue oxygen partial pressure, PO2, was determined by numerically solving:
k
∂P
∂t
= Dk∇2P +Kk
(
1− P
P0
)
−M0 P
P + Pcrit
where D and k are oxygen diffusivity and solubility in tissue, respectively, M0 is the max-
imal tissue oxygen consumption, Pcrit is the PO2 at which consumption is half V O2, P0 is
the average capillary PO2 and K is the rate of oxygen transport from the capillaries into
the tissue. The parameters used in our model are summarized in Table 4.1.
This model assumes the tissue is homogeneously consuming oxygen and that there is a
homogeneous supply of oxygen from the capillaries. Similar models were implemented in
previous studies to predict tissue oxygenation [24, 38].
The temporal derivative was discretized using an implicit-explicit method similar to [40]
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Table 2.1: Parameters used in mathematical model.
Parameter Value Reference
D 2.41× 10−5 cm2/s Bentley et al. [35]
k 3.89× 10−5 mL O2/mL/mmHg Mahler et al. [36]
M0 1.57× 10−4 mL O2/mL/s Sullivan & Pittman [37]
K 30 mmHg Goldman [38]
P0 48 mmHg Goldman [38]
Pcrit 0.5 mmHg Honig & Gayeski [39]
and the spatial derivatives were discretized using a second order central difference scheme.
In this scheme, the linear source term was evaluated at the current time step, where as the
other terms were evaluated at the previous time step. This scheme was chosen since it is fully
explicit and has greater stability than the forward Euler scheme. The numerical solution was
parallelized on a graphical processing unit (GPU) and implemented in C++/CUDA. The
numerical grid was spatially decomposed onto a 1024-core GPU. A four-minute simulation
with one million spatial nodes was solved in under five minutes. Computation time is limited
by the solution write-out frequency.
2.3 Results
Five gas exchange windows were patterned into glass slides to facilitate positioning of the
muscle relative to the exchange window (Figure 2.3). Windows were designed to be 200 by
400 µm. The spacing of the windows was chosen to allow for regions between the windows
that are unaffected by the change in O2. This was verified with our mathematical model;
see Figure 2.4. Dark markings can been seen around the edges of the windows; this is due
to the laser fabrication process. It can be noted that these marks only appear on one side
of the glass slide. We chose the non-marked side to be in contact with the muscle to ensure
that the markings are out of the focal plane when focused on the muscle; this can be seen
in Figure 2.3 panel C.
We used a model of O2 transport that was modified from that used in [24, 38] to predict the
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Figure 2.3: Gas exchange window design. Panel A shows a diagram of the design of the gas
exchange windows. Panel B shows a 4X micrograph of the two of the exchange windows cantered
in the field of view. Dark markings can be seen around the edges of the window. Panel C shows a
20X micrograph of an exchange window focused on the edge closest to the objective. Panel D shows
a 10X functional image of the minimum intensity values over time.
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distribution of O2 in the tissue. This model only considers diffusion, neglecting convective
effects caused by RBCs transporting O2. The model suggests that only a small area will be
affected by the window (Figure 2.5).
Figure 2.4: Computational simulation predicting the extent of diffusion between the five windows.
Contour map of the steady-state O2 distribution in the tissue around the gas exchange windows. The
displayed plane is oriented with the imaging plane of the microscope and at a depth of 25 µm into
the tissue from the surface of the glass slide.
To verify that the exchange window is affecting RBC SO2, we performed step changes in gas
O2 and measured the resulting RBC SO2. At baseline, the gas composition contained 5%
O2, 5% CO2, and balance N2. After one minute, the gas composition was changed to 2 %
O2, 5% CO2 and balance N2. An example of a step change for various capillaries in the field
of view is shown in Figure 2.6. After the drop in gas chamber O2, the SO2 drops rapidly then
steadily increases. This increase may be explained by the increased flow rate in response to
the low O2. It can also be noted that the trend is similar for all capillaries in the field of view.
A further demonstration of the desaturation capabilities of this device are shown in Figure
2.7. This figure shows the distribution of capillary SO2 values when the window O2 is set
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Figure 2.5: Predicted oxygen distribution. The top pannel shows an intravital video minimum
intensity functional image with contour lines displaying constant oxygen; each line is 2 mmHg apart.
The model assumes the plane is 25 µm from the surface of the window. The bottom panel shows a
colormap of the oxygen distribution as a function of depth in the tissue.
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Figure 2.6: Capillary SO2 in response to a step change in O2. The top panel shows the minimum
intensity function image of the field of view. The capillaries analyzed are identified by white boxes,
with arrows to indicate the direction of RBC flow, and the white dashed line indicates the position
of the exchange window. The bottom panel shows RBC SO2 as a function of time; the time at which
O2 was changed is indicated with the black dashed line.
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to 2%, 5% and 7% (5% CO2 and balance N2). These results demonstrate the large varia-
tions in RBC SO2 experienced in the microcirculation, even when subjected to variations in
window O2. The variations are probably due to the variability in RBC supply rate between
vessels, which vary from approximately 2 RBC/s to 40 RBC/s in this field of view.
80 µm
Figure 2.7: Distribution of RBC SO2 in response to three window O2 levels (2%, 5% and 7%). The
top panels shows the minimum intensity functional image of the analyzed field of view; the analyzed
capillaries are indicated with white boxes. The bottom panel shows the distribution of the average
capillary SO2 binned into 1 second intervals for window O2 of 2% (orange), 5% (blue) and 7% (red).
Histogram bins are partially transparent to show the overlap.
The computational model was also used to verify how quickly changes in chamber O2 affect
tissue O2 at varying depths in the tissue. The model assumes the gas composition at the
window changes instantly; thus the model is determining the temporal diffusion limitation.
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Figure 2.8 A shows the simulation results for a step change in O2 from 5% to 2% centred in
the window at varying tissue depths. The results of a square wave in O2 are shown in panel
B. The simulation demonstrates that diffusion reaches steady-state within 3 seconds of the
the step change. The delay in the change in chamber O2 was measured experimentally using
a PO2 sensor in the outlet of the gas channel; typical delays are on the order of 2 seconds.
Thus, we expect a total delay of 5 seconds.
A B
Figure 2.8: Predicted time-dependent changes in tissue O2. Panel A shows predicted tissue O2 for
a step change in chamber O2 for different depths in the tissue. Panel B shows the predicted tissue
O2 in response to a square wave in chamber O2 (one minute of 5% O2, two minutes of 7% O2, two
minutes of 2% O2 and one minute of 5% O2).
To demonstrate that the device can induce flow rate responses, we measured both RBC
SO2 in selected in-focus capillaries as well as RBC supply rate in response to a square wave
change in chamber O2. The square wave consisted of one minute of 5% O2 followed by
two minutes of 7% percent, two minutes of 2% percent and one minute of 5% with 3% and
balance N2. The analyzed field of view and results of the square wave are shown in Figure
2.9.
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40 µm
Figure 2.9: Oxygen saturation and supply rate change in response to square wave oxygen challenge.
The top panel shows the minimum intensity function image of the analyzed field of view at 20X
magnification. The analyzed capillary is indicated with a white box. The bottom panel shows the
induced SO2 changes along with the corresponding change in RBC supply rate. The black dashed
lines indicate the time at which the chamber O2 was changed.
2.4 Discussion
In this study, we developed a modular gas exchange platform to deliver a localized gas
composition to the surface of tissue for use in intravital microscopy studies. Our platform
is able to change RBC SO2 to capillaries within a localized area of approximately 560 by
360 µm (Figure 2.5). The changes in capillary RBC O2 were demonstrated both experi-
mentally (Figures 2.6, 2.7) and computationally (Figure 2.5); the later was able to predict
the extent of the affected area. This gas exchange platform is able to induce both increased
and decreased microvascular flow response to changing levels of O2. The computational
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model predicts that O2 diffusion into the tissue will reach steady-state within 5 seconds
of changing the chamber O2. This prediction may be impacted by the presence of blood
vessels, for which the model does not account.
In previous work, we used a smaller gas exchange window to induce RBC SO2 changes
[24]. Ghonaim et al. suggested that not enough capillaries were stimulated to elicit a flow
response [25, 26]. This is supported by the use of a larger gas exchange window to induce
RBC SO2 changes in more capillaries to which the vasculature responded [26]. In the cur-
rent study, we used a window size that was larger than that used in [24] but smaller than
that used in [26] and were able to get consistent vascular response with our chamber. The
changes in SO2 in both [24, 26] were consistent with those in our chamber. This finding
supports the hypothesis that the ATP release signal is additive since we are affecting more
capillaries than in [24].
Various studies in the literature have been successful in causing changes in RBC SO2 both
in vivo and ex vivo [1–8]. One approach is to alter the inspired O2 levels as in [3], result-
ing in changed RBC SO2, though this may result in systemic hyper/hypoxia [9]. Another
approach involves using superfusion solutions with different gas compositions to bathe the
tissue in order to control the surface O2 levels [5, 8]. While this method confines the changes
in O2 to the tissue being studied, the changes affect the entire muscle surface. Additionally,
these methods may affect the physiological pathways as molecules may be continuously
washed away with the superfusate. Superfusion solutions are likely to cause confounding
results and make isolating specific vessels challenging since they may be affecting mecha-
nisms at difference levels of the vasculature [9]. Further, due to the low solubility of O2 in
water, superfusion solutions have a limited in their ability carry O2. For these reasons, gas
exchange chambers may be more advantageous than superfusion solutions in the investiga-
tions of localized O2 regulation.
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Despite the many benefits of the approach employed in this work, there are a few challenges
that are worth noting. Firstly, due to the opening in the glass, the tissue view through the
window is on a different focal plane than the surrounding tissue at the same tissue depth.
Because of this, it is not possible to focus on capillaries in and out of the window at the
same tissue depth simultaneously. However, due to the optical clarity outside the window,
we are able to focus on capillaries outside of the window, enabling us to look at the effects
of changing gas composition on the surroundings.
Another challenge associated with this experiment is placement of the muscle over the ex-
change windows. This requires careful manipulation of the muscle in order to place the
muscle over the windows such that the window would be affecting the capillary bundle of
interest. It seems that moving the muscle multiple time may increase the likeliness that the
muscle become stressed and stops responding to changes in O2. Including more windows
closer together would increase the probability of one of the windows being over an interest-
ing area in the muscle, though care must be taken to ensure that the other windows do not
affect vessels that come into the area of interest.
In the current study, the longer side of the window was placed perpendicular to capillaries,
though it is just as easy to rotate the windows ninety degrees such that the long direction
is oriented with the capillaries. This allows for stimulation of the capillaries along their
length without crossing over too many networks.
It would be interesting to determine if changes in capillary RBC distribution are due to
simple rheology (i.e. bifurcation law) or if there are other active mechanisms in place, such
as pericytes to control flow in capillaries. One interesting application of this platform would
be to position the window over multiple capillaries fed from the same arteriole to determine
if their distribution of flow rates remains constant in response to oxygen; this should be
the case if flow is dictated by simple rheology since capillaries cannot change their diameter.
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This device is well-suited to studying oxygen regulation at the microvascular level. For
instance, this platform could be used to determine if stimulating capillaries in one bundle
affects all bundles connected to the same feed arteriole. Such an experiment could help
support the SO2-dependent ATP release from RBC hypothesis. Conversely, if the O2 sen-
sor is located in the extravascular space rather than the RBCs, the O2 exchange platform
could further be used to stimulate areas of the muscle that lack capillaries to investigate
the presence of an RBC sensor.
Additionally, this approach could be used in ex vivo and in vitro studies where the control
of gas composition needs to be locally confined. For example, this gas exchange platform
could be used in conjunction with a microfluidic device to desaturate flowing RBCs as sug-
gested in [41, 42]. As proposed in these studies, such a device could probe the dynamics of
the ATP release mechanism if it is indeed caused by RBC desaturation.
In summary, we have developed a gas exchange platform capable of causing local changes
in RBC SO2. We have also shown that these changes are consistent with the ATP release
hypothesis that multiple capillaries need to be stimulated in order to elicit a microvascular
flow rate response. While our device stimulates a large enough region to obtain a flow
response, it is also localized enough that we will be able to probe individual parts of the
microvascular bed, and it is optically clear enough that we can observe the response both
in the stimulated, as well as neighbouring regions. This tool offers exciting possibilities to
study microvascular regulation, and may be able to definitively determine the location of
the elusive oxygen sensor.
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Chapter 3
A Computational Model of a
Microfluidic Device to Measure the
Dynamics of Oxygen-Dependent
ATP Release from Erythrocytes1
3.1 Introduction
In the human body, the regulation of oxygen transport is an important process to ensure
that the demands for oxygen are met. The circulatory system has various mechanisms re-
sponsible for the delivery of oxygen to regions of high metabolic activity. Oxygen regulation
can occur on a large scale or locally within specific tissue. The vessels responsible for local
regulation mechanisms are known to be the small arterioles and capillaries, which comprise
the microcirculation.
Erythrocytes have been shown to release ATP in response both to low erythrocyte hemoglobin
oxygen saturation (SO2) [2, 3] and to increased shear stress on the erythrocyte membrane
[2, 4]. Both mechanisms are suspected to be involved in the regulation of flow in the mi-
crocirculation. In a recent study, the dynamics of shear-dependent release of ATP from
erythrocytes was measured by flowing erythrocytes through a constriction in a microfluidic
1A version of this chapter has been published in PLoS One [1].
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device to induce a brief period of increased shear stress [4]. The authors report that the
ATP release occurred within 25 to 75 milliseconds after the period of increased shear.
The oxygen-dependent release of ATP is hypothesized to be a mechanism involved in regu-
lating the distribution of oxygen within the microvasculature, where the erythrocyte plays
the role of the oxygen sensor [5]. An important aspect of this hypothesis is the time re-
quired for ATP release to occur following a change in SO2, since this determines the spatial
accuracy with which the erythrocyte can signal for vasodilation. Our ultimate goal is to
measure the dynamics of oxygen-dependent release of ATP by applying a similar approach
to the study by Wan et al. [4]. In the place of the constriction in the microfluidic device, we
will use an oxygen-permeable membrane to cause a rapid change in SO2 as the erythrocytes
flow through the channel.
Understanding this mechanism may also have important clinical implications. In patients
with type II diabetes, ATP release is known to be significantly lower for the same change
in oxygen saturation [6]. However, we do not know if the time course is also altered in type
II diabetes and other cardiovascular diseases [6].
Several concerns must be assessed to design an effective microfluidic device for the study
of oxygen-dependent ATP release. First, we must determine whether a practical device can
cause a sufficient drop in SO2 to cause ATP release and whether the change in SO2 is fast
enough to measure the dynamics. Second, we must assess whether the experimental setup
can resolve ATP release times as fast as 25 milliseconds. In this study, we will describe a
computational model of a microfluidic system to address the aforementioned concerns.
The microfluidic device should be designed such that the majority of the channel is oxygen-
impermeable and should contain an oxygen-permeable region at which the oxygen partial
pressure (PO2) is held at a lower PO2 than that of the blood. As the blood passes the
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oxygen-permeable region, oxygen diffuses out of the blood causing a drop in SO2. We im-
plemented a similar approach to decrease PO2 in a 2011 study of methods for localized
oxygen delivery in vivo [7]. In the current study, oxygenated blood would flow through
the channel at a constant flow rate to produce a steady state distribution of SO2 and ATP
levels within the channel. A possible design for a microfluidic device is shown in Fig. 3.1.
gas stream maintaining PO2 = PL
O2 permeable membrane (DmKm)
erythrocyte suspension with luciferin/luciferase (DpKp)Q
z = 0 z = a z = b z = L
y = -h
T
glass O2 impermeable
glass O2 impermeable
y = h
cell free layer τ
A
B
inlet outlet
Top View at y = h
W
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Figure 3.1: Two-dimensional representation of a microfluidic device for measuring
oxygen-dependent ATP release from erythrocytes. A. shows the side view along the centerline.
This view of the diagram is to scale; the vertical dashed lines indicate where the diagram is broken to
allow for the entire device to be shown. B. shows the top view; the dotted line indicates the centerline.
Note: this view of the diagram is not to scale.
To measure ATP levels, the blood in the system will be mixed with a solution of luciferin
and luciferase as it enters the microfluidic device. Luciferin and luciferase react with ATP,
producing light proportional to the concentration of ATP [8, 9] . The light intensity levels
will be measured using a microscope and still-framed camera with appropriate exposure
time. Since ATP release will be measured in steady state, changes in time can be measured
as changes in position along the channel. Exploiting time in terms of distance allows for the
measurement of time on the order of milliseconds without having to use a light detection
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system with high temporal resolution. In this paper we present a mathematical model of the
microfluidic system to aid in the design the experimental setup and to gain further insights
into this phenomenon. The mathematical model will also give us the tools necessary to
analyze future experimental results.
3.2 Methods
3.2.1 Overview of Model
The model is comprised of a number of coupled modules, each corresponding to a compo-
nent of the mass transport and light detection system. The first underlying module in this
simulation is a model for the hemodynamics of system. This module determines how the
blood plasma and erythrocytes will behave and interact as they flow through the microflu-
idic device. Based on the hemodynamic module, a second module for oxygen transport was
developed. This module describes the convection and diffusion of oxygen within the blood
and it also includes the relationship between PO2 and SO2.
A module for ATP release was added based on both SO2 and the hemodynamic module.
The ATP module describes the rate of ATP release throughout the microfluidic device. A
simple linear relationship between SO2 and ATP release rate was used, as this is sufficient
to determine whether the device is capable of measuring ATP. A linear model was also used
in a previous study [10] . A time delay term was included in this module, which accounts
for the time required for ATP to be released following the change in SO2. This term was
included to ensure the device was capable of measuring the dynamics of ATP release. A
further module for ATP transport was constructed based on the diffusion and convection of
ATP in the blood plasma. The degradation of ATP due to the reaction with the luciferin
and luciferase solution was also included.
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In addition to the degradation of ATP, a module for the light generated by the luciferin
and luciferase reaction was developed. This luminescence module was based on the kinetics
of the reaction between ATP and the luciferin and luciferase solution. From this module,
the amount of light coming from the system was determined and used to calculate the light
intensity signal that would be measured by a digital camera. This module includes both
the attenuation of light as it passes through hemoglobin based on extinction coefficients
and the efficiency of a scientific digital camera for measuring light levels at a wavelength of
560 nm. In this configuration, image acquisition is taken from the top of the channel to ac-
quire the information closest to the oxygen-permeable membrane. A detailed mathematical
description of each module follows below.
3.2.2 Hemodynamic Module
The geometry of this model is presented in Fig. 3.1; it considers a slice in the yz-plane
along the centerline. Blood flow is assumed to be viscous and in steady state. The module
incorporates a core region of blood flow mixed with erythrocytes where hematocrit is as-
sumed to be constant and a cell-free plasma layer along the channel walls where hematocrit
is assumed to be zero.
In this model, velocities in the x and y directions are assumed to be zero. The velocity
profile of the blood plasma was derived from the Navier-Stokes equations for fluid dynamics.
Steady state is assumed, and the shear stress between the cell-free layer and core region is
assumed to be equal at the interface. Equation 3.1 governs the flow velocity of the blood
plasma.
vp(y) =
3Q
4w
[
h3 +
(
µp
µc
− 1
)
y3i
]

((
h2 − y2i
)
+
µp
µc
(
y2i − y2
))
0 ≤ y ≤ yi(
h2 − y2) yi ≤ y ≤ h (3.1)
In this equation Q is the flow rate, h is half the height of the channel, w is the width of the
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channel, y is the distance from the center of the channel, yi is the position of the interface
between the cell-free layer and the cell-plasma mixture, µp is the dynamics viscosity of the
cell-free layer and µc is the dynamic viscosity of the cell-plasma mixture and is calculated
empirically based on the work of Pries et al. [11] .
The erythrocytes flow at a velocity slower than the plasma due to slipping. The slip velocity,
slp, defines the magnitude of slipping between the plasma and erythrocytes [12]. Equation
3.2 governs the flow velocity of the erythrocytes.
vRBC = vp (1− slp) (3.2)
Tube hematocrit in a flowing system is different from inlet or discharge hematocrit, and is
defined as the fraction of erythrocytes flowing in the core region of blood flow [13]. Equation
3.3 defines the relationship between tube hematocrit (HT ), discharge hematocrit (HD) and
the channel height. τ is the cell-free plasma layer thickness.
HT
HD
=
(1− slp)(
2− (1− τh)) (3.3)
3.2.3 Oxygen Transport Module
Oxygen movement is dictated by diffusion and convection in a flowing system. In this
module, oxygen is assumed to diffuse in the y-direction and to move by convection in the
z-direction. Oxygen is also transported by erythrocytes through the binding of oxygen
to hemoglobin. Equation 3.4a governs oxygen transport in the cell-free plasma layer and
Equation 3.4a governs oxygen transport in the blood mixture [12].
PO2 is the partial pressure of oxygen; Dp is the diffusion coefficient of oxygen in blood
plasma; Kp and KRBC are the oxygen solubility in the cell-free plasma layer and blood
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mixture respectively; [HbT ] is the total hemoglobin concentration, and is the derivative
of the Hill equation (see Eq. 3.5 below). The initial condition is described by Equation
3.4c and the boundary conditions are described by Equation 3.4d. The oxygen-permeable
membrane is present on the upper wall of the channel and extend from z = a to z = b
where the PO2 is set to PL. Dm and Km are the diffusion coefficient and solubility of
the oxygen-permeable membrane respectively. T is the thickness of the oxygen-permeable
membrane.
vp
∂PO2
∂z
= Dp
∂2PO2
∂y2
(3.4a)(
vp (1−HT ) + vRBCHT KRBC
Kp
(
1 +
[HbT ]
KRBC
dSO2
dPO2
))
∂PO2
∂z
= Dp
∂2PO2
∂y2
(3.4b)
PO2(y, 0) = P0, −h ≤ y ≤ h (3.4c)
∂PO2
∂y
(h, z) = 0
0 ≤ z ≤ a,
b ≤ z ≤ L
∂PO2
∂y
(−h, z) = 0 0 ≤ z ≤ L (3.4d)
DpKp
∂PO2
∂y
(h, z) = DmKm
PL − P (h)
T
a ≤ z ≤ b
SO2 was calculated based on the Hill equation, and depends on the PO2 output of the
oxygen transport module. Equation 3.5 is the Hill equation, where N is the Hill coefficient,
which characterizes the binding cooperativity of hemoglobin, and P50 is the PO2 at 50%
saturation.
SO2 =
PON2
PON2 + P
N
50
(3.5)
3.2.4 ATP Release Module
This module describes ATP release rates and assumes that the relationship between ATP
release rate and SO2 is linear with a minimum release rate (Rmin) when hemoglobin is fully
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saturated and a maximum release rate (Rmax) when it is fully de-saturated. Finally, the
module assumes that there is a delay between the change in saturation and the change in
ATP release rate. Equation 5.12 governs ATP release rate for these assumptions, where td
is the time delay.
R = (Rmin −Rmax)SO2(y, z − vptd) +Rmax (3.6)
3.2.5 ATP Transport Module
This module assumes that ATP diffuses in the y-direction and moves by convection in
the z-direction. It assumes that ATP cannot diffuse through the erythrocyte membrane.
This module includes erythrocytes as an ATP source and the depletion of ATP due to the
reaction with luciferin and luciferase. Equation 3.7 governs ATP transport, where [ATP ]
is the concentration of ATP; DATP is the diffusion coefficient of ATP in blood plasma and
kt is the reaction rate constant for the luciferin and luciferase reaction with ATP.
vp
∂[ATP ]
∂z
(1−Ht) = DATP ∂
2[ATP ]
∂y2
(1−HT ) +R ·HT − kt[ATP ] (1−HT ) (3.7)
The differential equation was solved assuming that there is no ATP flux at the channel walls
and that the luciferin and luciferase solution is being mixed at the inlet of the channel. It
is assumed that there is no ATP entering the channel at the inlet and there is no ATP flux
at the O2-permeable membrane.
3.2.6 Luminescence Module
The luminescence in this system is derived from the kinetics of the reaction between ATP
and luciferin/luciferase. Equation 3.8 shows the complete reaction [9].
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ATP + luciferin + O2
luciferase−−−−−⇀↽ − oxyluciferin + AMP + PPi + CO2 + hν (3.8)
This reaction has first order kinetics such that the rate of reaction only depends on the
concentration of ATP [8] ; therefore, the rate at which light is produced is proportional
to the rate of ATP consumption. For the amount of ATP released from erythrocytes, the
concentration of the luciferin and luciferase solution will be much greater than that of ATP;
therefore product inhibition can be assumed to be negligible. Equation 3.9 describes the
rate, I, at which light is produced, where α is the quantum efficiency, V is the volume of
each voxel, NA is Avogadro’s number and kt is the rate constant of the reaction [9] . The
reaction constant kt varies typically between 0.1 and 1.0 s
-1 [9].
I = α · V NA · kt · [ATP ] (3.9)
3.2.7 Optics Module
Photon detection is based on the number of photons that reach the digital camera’s charge-
coupled device (CCD) and the device’s ability to undergo the photoelectric effect. This
module accounts for photon attenuation by hemoglobin and the fact that a point source
emits light in all directions. Equation 3.10 describes the number of photons acquired per
pixel; where ts is the camera’s shutter speed; Apixel is the surface area of the pixel and µ is
the attenuation coefficient.
γ =
∫ 2h
0
I · ts ·Apixel e
−κy
4piy2
dy (3.10)
It is known that oxyhemoglobin and deoxyhemoglobin have different attenuation coefficients
depending on wavelength. Equation 3.11 describes the light attenuation coefficient through
the blood mixture as a function of saturation, where κp, κHb and κHbO2 are the attenuation
coefficients of the blood plasma, deoxyhemoglobin and oxyhemoglobin respectively at the
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wavelength of light produced by the luciferin/luciferase reaction with ATP, 560 nm.
κ = (1−HT )κp +HT ((1− SO2)κHb + SO2κHbO2) (3.11)
The signal read by the device comes from the amount of electrons released by the photons
collected from the photoactive region of each well of the CCD. Thus the signal depends
on the efficiency of the photoelectric effect (η) and the amount of photons collected on the
surface of each well. Equation 3.12 describes the signal read by the device, where Stotal is
measured in electrons.
Stotal = η · γ (3.12)
The device reads out each well and converts the number of electrons measured into a
digital signal that depends on the memory information of the device. Equation 3.13 gives a
measurement of the output signal relative to the maximum measurable signal by the CCD;
this will be referred to as the relative output signal. The full-well capacity (FWC) of the
CCD is the maximum number of electrons that each well can hold.
Srelative =

Stotal
FWC
, Stotal < FWC
1, Stotal ≥ FWC
(3.13)
3.2.8 Simulations
All numerical analyses were done in Mathworks MATLAB 7.11.0 (R2010b). Grid spacing
for the model was 321 × 4000 (y-z). The parameters of the model are specified in Table
4.1. All simulations reached a stable solution. The default simulation was performed with
a grid spacing of 321 × 4000, 642 × 8000 and 1284 × 16000; these simulations reached the
same stable solution.
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Table 3.1: Model Parameters
Parameter Variable Value
Flow Rate (µL/min) Q 7.8
Device Height (µm) H 100
Device Width [13] (µm) W 1500
Plasma Viscosity (Pa·s) µp 0.001
Slip Coefficient [12] slp 0.1
Discharge Hematocrit HD 0.2
Plasma Layer Thickness (µm) τ 1
O2 Diffusivity in Plasma [12] (µm
2/s) Dp 2750
O2 Solubility in RBCs [12] (µM/mmHg) KRBC 1.47
O2 Solubility in Plasma [12] (µM/mmHg) Kp 1.33
Total Heme Concentration [12] (µM) HbT 5350
Inlet PO2 (mmHg) P0 150
O2-Permeable Membrane PO2 (mmHg) Pb 10
O2-Permeable Membrane Start Position (µm) a 7000
O2-Permeable Membrane End Position (µm) b 7700
Device Length (µm) L 14000
O2 Diffusivity in O2-Permeable Membrane (µm
2/s) Dm 160000
O2 Solubility in O2-Permeable Membrane (µM/mmHg) Km 17.959
O2-Permeable Membrane Thickness (µm) T 100
Hill Coefficient [12] N 2.7
Partial Pressure at 50% Saturation [12] (mmHg) P50 27
Minimum ATP Release Rate (µM/s) Rmin 0
Maximum ATP Release Rate (µM/s) Rmax 14
ATP Release Time (s) td 0
ATP Diffusivity in Plasma [14] (µm2/s) DATP 475
ATP/Luciferin Reaction Rate [9] (s-1) kt 0.1
Quantum Efficiency [9] α 0.88
Shutter Speed (s) ts 10
Pixel Surface Area* (µm2) Apixel 166.41
Plasma Attenuation Coefficient (µm-1) kp 0.1
Oxyhemoglobin Attenuation Coefficient** (µm-1) kO2Hb 0.040176
Hemoglobin Attenuation Coefficient** (µm-1) kHb 0.066261
Camera Efficiency* η 0.7
Full Well Capacity* (electrons) FWC 22000
Units are given in the first column. One asterisk (*) indicates parameters taken from the specification
of Qimaging’s Rolera XR camera. Two asterisks (**) indicates parameters calculated from tabulated
molar extinction coefficients for hemoglobin in water at 560 nm; these values were compiled by Scott
Prahl (prahl@ece.ogi.ed).
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3.3 Results
The computational model simulated experiments with the parameters specified in Table 1.
The parameters that are varied during the simulations are summarized in Table 2. The
first simulation was used to test the feasibility of the experimental setup. This simulation
shows that the PO2 decreases from 150 mmHg to below 57 mmHg in the vicinity of the
oxygen-permeable membrane and to 95 mmHg across the entire width of the channel 3 mm
downstream from the end of the membrane (Fig. 3.2A). This simulation also shows that the
SO2 decreases from 99% to below 65% in the immediate vicinity of the oxygen-permeable
membrane (Fig. 3.2B) but rapidly rises back up to 97% within 1.9 mm downstream. It
should be noted that this erythrocyte resaturation occurs due to the diffusion of oxygen
from regions further from the membrane that were initially less affected by low O2 at the
membrane surface. The ATP concentration, accounting for both the release from erythro-
cytes and degradation by luciferin/luciferase, is shown to reach a peak value of 0.2 µM in
the vicinity of the oxygen-permeable membrane with the concentration decreasing immedi-
ately after the end of the membrane (Fig. 3.2C). The relative output signal shown in Fig.
3.2D is the accumulated light produced by the luciferin/luciferase reaction as measured by
the camera; this measurement is normalized by the maximum signal measurable by the
camera for the parameter settings given in Table 1. The relative output signal begins a
rapid increase from 0.032 at the position of the beginning of the membrane and reaches a
maximum value of 0.191 at the end of the membrane.
The second simulation was used to analyze the choice of channel height and its effect on
the resulting output signal (Fig. 3.3). All the channel heights show a rapid increase at
the beginning of the oxygen-permeable membrane, this corresponds to ATP release being
turned on due to the rapid desaturation of the erythrocytes. However, the 25 and 50 µm
channels do not show a clear turn off of ATP release; this is because the O2-permeable
membrane reduces O2 levels across the entire channel and hence the erythrocytes do not
resaturate downstream of the membrane (Fig. 3.3A).
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Table 3.2: Simulation Parameter Range
Parameter Range Simulation Number
Device Height (µm) 25 – 400 2
Membrane Permeability (M·µm2/(mmHg·s)) 0.06 – 3.84 7
Flow Rate (µL/min) 3.30 – 18.24 4
ATP Release Time (s) 0.00 – 4.00 3, 4
Maximum ATP Release Rate (µM/s) 10.0 – 25.0 5
Minimum ATP Release Rate (µM/s) 0.0 – 1.5 5
ATP/luciferin Reaction Rate (s-1) 0.0 – 1.0 6
Model parameters that were varied in each of the simulations along with the range of the parameter
values. Units are given in the first column and simulation number is indicated in the last column.
The third simulation was used to analyze the change in output signal when varying the
ATP release time. Increasing release times resulted in a downstream shift in the output
signal peak by 1304 µm per second of ATP release time. It should be noted that for this
case the mean velocity in the channel is 1263 µm/s (Fig. 3.4).
The fourth simulation was used to analyze the effect of flow rate on the maximum signal
strength and spatial resolution (Fig. 3.5). Increased flow rate resulted in an increased flux
in oxygen across the oxygen-permeable membrane (Fig 3.5A). Increased flow rate resulted
in increased spatial resolution (Fig. 3.5B); however, it also resulted in decreased signal
strength (Fig. 3.5C). For a 5.5 fold increase in flow rate, signal strength decreases by a
factor of 3.6. For the 25-millisecond ATP release time, the peak signal shifts linearly with
flow rate.
The fifth simulation considered two parameters that control the ATP release module. The
first parameter determines the release rate when the erythrocyte is fully saturated; this is
the minimum ATP release rate, Rmin. The second parameter determines the release rate
when the erythrocyte is fully desaturated; this is the maximum ATP release rate, Rmax.
The results of increasing Rmin and Rmax are shown in Figs 3.6A and 3.6B, respectively.
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Figure 3.2: Shows the simulation results for the parameters in Table 1. A. displays the
oxygen partial pressure (mmHg) as a function of position (µm) throughout the microfluidic device.
B. displays hemoglobin oxygen saturation as a function of position (µm) throughout the microfluidic
device. C. displays the ATP concentration (µM) as a function of position (µm) throughout the
microfluidic device. D. displays the relative output signal as a function of longitudinal position.
Changing the minimum and maximum ATP release rates resulted in a change in the shape
of the output signal.
The sixth simulation was used to investigate the effect of the rate of the luciferin/luciferase
reaction on the concentration of ATP in the channel; three degradation rates (0, 0.1, 1.0
s-1) were simulated. Although the case with zero degradation does not result in an output
signal that can be measured by the camera, this simulation shows the ATP concentration
due to the release from erythrocytes (Fig. 3.7A). As the degradation rate increases, ATP
concentration in the channel decreases. With increasing degradation rate, the amount of
light produced increases and hence the signal strength as measured by the camera also in-
creases. This results in the apparent paradox that the highest signal strength occurs with
the lowest ATP concentration in the channel. The total concentration of ATP in the channel
for the zero degradation case is a factor of 1.3 and 4.9 larger than the total concentration
for the degradation rates of 0.1 s-1 (Fig. 3.7B) and 1.0 s-1 (Fig. 3.7C), respectively. The
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Figure 3.3: Shows the effect of increasing channel height. A. displays the mean hemoglobin
oxygen saturation across the channel as a function of position (µm) along the microfluidic device for
channel heights of 25, 50, 100, 200 and 400 µm. B. displays the relative output signal as a function
of position (µm) for channel heights of 25, 50, 100, 200 and 400 µm.
maximum output signal is 5.2 fold larger with a degradation rate of 1.0 s-1 compared to 0.1
s-1 (Fig. 3.7D).
The seventh simulation was used to analyze the effect of the permeability of the oxygen-
permeable membrane on SO2 (Fig. 3.8). The membrane with the highest permeability
(3.84 (M µm2)/(mmHg s)) had the ability to cause a maximum decrease from 99% to 12%
whereas the membrane with the lowest permeability (0.06 (M m2/(mmHg s)) was able to
cause a maximum decrease from 99% to 53%.
3.4 Discussion
The first simulation predicts that this design of a microfluidic device will be able to cause a
sufficient drop in oxygen partial pressure across the width of the channel (Fig. 3.2A). This
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Figure 3.4: Shows the effect of increasing ATP release times. The figure displays the
relative output signal for increasing ATP release times (0 s, 1 s, 2 s and 3 s) as a function of
longitudinal position (µm) throughout the microfluidic device. ATP release turn on and turn off
time is indicated on the graph for the 1 s delay time.
finding also verifies that the design of the device is effective for the purpose of causing a
decrease in oxygen saturation. From this simulation, it is evident that a similar experimen-
tal procedure to that of the study of shear-dependent ATP release [4] can be repeated with
this microfluidic device to study the oxygen-dependent release of ATP.
The first simulation also confirms that a digital camera will be able to measure a signal
given the small concentration of ATP released from red blood cells using an exposure time
of 10 seconds. The advantage of using a digital camera over a photomultiplier tube (a
common method of acquiring low intensity light) is the ability to acquire all of the spatial
light intensity data simultaneously at a high spatial resolution. The resulting image in
combination with the simulation can be used to estimate the ATP concentration prior to
degradation by the luciferin and luciferase reaction.
From the results of simulation 2 (Fig. 3.3), larger channel heights cause a peak in the
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Figure 3.5: Shows the effects of flow rate on the system. A. displays the oxygen flux (µL
O2/min) across the oxygen-permeable membrane as a function of flow rate (µL/min) using a log-log
scale. The data lie on a straight line with slope of 0.37. B. displays the local maximum shift (mm)
caused by a 25 ms delay in ATP release as a function of flow rate (µL/min). The data lie on a
straight line with slope 4.2. C. displays the magnitude of the local maximum of the output signal as
a function of flow rate (mL/min) using a log-log scale. The data lie on a straight line with slope of
20.75.
output signal, allowing us to determine the location where ATP release turns off as the
erythrocytes resaturate with oxygen from deeper in the channel.
Varying ATP release times and analyzing the corresponding output signals shows a visible
change in the output signal curve. Increasing the ATP release time results in a downstream
shift in the signal peak. This implies that ATP release time is measurable with this setup
provided that the system remains in steady state. This allows us to use our system of high
spatial resolution to obtain high temporal resolution. Measuring the distance between the
beginning of the oxygen-permeable membrane and the start of the rapid increase in signal
gives us information about the amount of time it take for ATP release to turn on. Measuring
the distance between the end of the oxygen-permeable membrane and the peak in signal
gives us information about the time it takes ATP release to turn off. In our model these
70
Figure 3.6: Shows the effect of ATP release rate parameters on output signal. A. displays
the relative output signal for increasing minimum ATP release rates (0.0 µM/s, 0.5 µM/s, 1.0 µM/s,
1.5 µM/s) as a function of longitudinal position (mm) in the microfluidic device. B. displays the
relative output signal for increasing maximum ATP release rates (10 µM/s, 15 µM/s, 20 µM/s, 25
µM/s) as a function of longitudinal position (µm) in the microfluidic device. The system is more
sensitive to changes in minimum ATP release rate.
two times are modelled as being the same, however, a recent study modelling the dynamics
of the signal transduction pathway for ATP release suggests they may be different [15].
Varying flow rate and analyzing the corresponding change in the peak signal position shows
that the system’s resolution increases as flow rate increases, allowing us to control temporal
resolution. However, the signal strength decreases with increasing flow rate. This finding
demonstrates that there is a compromise between our system’s resolution and the amount
of measurable signal. Additionally, oxygen flux across the oxygen-permeable membrane
increases with increasing flow rate; this follows a power law with a power of 0.37. This find-
ing is consistent with mass transport theory, which results in a power of 1/3 for high shear
Pe´clet number [16]. The small discrepancy in the power may be due to the inhomogeneous
distribution of oxygen throughout the oxygen-permeable membrane and because the shear
Pe´clet number for our simulations may not be sufficiently large. The shear Pe´clet number
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Figure 3.7: Shows the effect of ATP degradation on output signal. A. displays ATP
concentration (µM) as a function of position (µm) throughout the microfluidic device where the blood
does not contain the luciferin/luciferase solution. B. displays ATP concentration (µM) as a function
of position (µm) throughout the microfluidic device where the blood contains the luciferin/luciferase
solution with a degradation rate of 0.1 s21. C. displays ATP concentration (µM) as a function of
position (µm) throughout the microfluidic device where the blood contains the luciferin/ luciferase
solution with a degradation rate of 1 s21. D. shows output signal as a function of longitudinal
position along the microfluidic device for the two degradation rates. The higher degradation rate
results in a larger output signal.
for oxygen transport in our simulations range from 108.78 and 601.72. Despite the increase
in O2 flux with increasing flow rate, the signal strength decreases due to the decrease in
erythrocyte transit time from leading to trailing edge of the membrane. As transit time
decreases there is less time for erythrocytes to release ATP.
The flow rates used in this study (3.30-18.24 µL/min) are much smaller than the flow rate
used in the study by Wan et al. (50 µL/min) [4], implying that the shear-dependent ATP
release can be ignored. Varying the exposure time is another parameter that can be con-
trolled to increase signal strength.
Another important finding from this study is that to calculate ATP release time, we need to
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Figure 3.8: Displays the effect of the permeability of the oxygen-permeable membrane
on oxygen saturation. This figure shows hemoglobin oxygen saturation near the oxygen-permeable
membrane as a function of time (s) for increasing permeability of the oxygen-permeable membrane
in units M·µm2/(mmHg·s).
know the velocity of the blood, which is variable across the device. Deciding which velocity
to use is necessary to calculate the correct release time. This time can be calculated using
our model.
ATP release rate and ATP concentration can be determined from the simulation, providing
useful information about the system that would be difficult to measure directly. Compar-
ing the simulations with and without the degradation due to the luciferin and luciferase
reaction (Fig. 3.7), it is shown that the concentrations of ATP in the system differ by over
a factor of two. This finding demonstrates that in order to determine the concentration of
ATP released by the erythrocytes in a dynamic system, the calculations must account for
the degradation due to the reaction. The light intensity profile measured by the camera
does not directly reflect the ATP concentration produced by the oxygen-dependent release;
this is due to the ATP degradation by the luciferin and luciferase reaction in a flowing
system. Fig. 3.7 demonstrates that different degradation rates can have a substantial ef-
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fect on the estimated ATP concentrations indicating that one must carefully determine
what the ATP degradation rate is for the experimental system used. Relying solely on the
measured light intensity signal may result in misinterpretation of the ATP release dynamics.
From the results of the sixth simulation (Fig. 3.8), it is demonstrated that with increasing
O2 diffusivity of the O2-permeable membrane, the drop in saturation becomes independent
of the diffusivity.
Varying the minimum and maximum ATP release rates independently and analyzing the
resulting output signal shows a measurable signal difference between the different parame-
ters of the ATP release module. This finding supports the objective of being able to study
the oxygen-dependent release of ATP because the model allows for the differentiation of
individual components of the ATP release module. Further, the model can be used with
the experimental procedure to adjust the three parameters (minimum and maximum release
rate and release time) in the model so they match the experimental results.
A recent study suggests that ATP release may be proportional to the rate of oxygen desatu-
ration rather than the magnitude of the saturation [15]. By varying the oxygen permeability
of the oxygen-permeable membrane, the model shows that the rate of desaturation may be
controlled. By varying the length of the membrane, we can control the magnitude of desat-
uration; this will allow for the verification of this theory (see Fig. 3.8).
As we gain a better understanding of the dynamics of the signalling pathway for ATP re-
lease, these can be incorporated into our simulation. Ultimately, model parameters could be
varied to yield the best fit with experimental measurements. Improving the model of ATP
release will allow it to be used for modelling local oxygen regulation in the microvasculature
in vivo and for the design and interpretation of in vivo experiments.
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The results of such experiments can then be compared to the ATP release magnitude and
dynamics that occur in cardiovascular disease. Finding differences between the ATP re-
lease magnitude and dynamics will allow the device combined with the model to be used to
screen blood from patients with cardiovascular disease to determine whether cardiovascular
disease is present.
In conclusion, a microfluidic device can be designed to produce a rapid decrease in the
oxygen saturation of erythrocytes across the width of the channel resulting in a measurable
ATP signal that can be analyzed for the dynamics of oxygen saturation-dependent ATP
release. In addition, this computational model is an effective tool to optimize the microflu-
idic experiment to be able to determine the time course of ATP release from erythrocytes.
Further, it can be used to determine other unknown parameters such as the minimum and
maximum ATP release rate. The model may also be used in the analysis of experimental
results that may be difficult to interpret, such as determining the concentration of ATP
in the system prior to the degradation from the luciferin and luciferase reaction and the
conversion of the spatial displacement of ATP release into ATP release time. The model
can also be modified based on experimental results to further develop the model leading
to a better understanding of the ATP release pathway. Further, this model is testable;
experimental measurements of oxygen saturations [17] and ATP concentrations [8] can be
made to justify the results of the model. In future studies, the model may be also used for
the analysis of systems in vivo where parameter may often be very difficult to measure.
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Chapter 4
Finite Element Model of Oxygen
Transport for the Design of
Geometrically Complex
Microfluidic Devices Used in
Biological Studies1
4.1 Introduction
Red blood cells (RBCs) have been shown to release adenosine triphosphate (ATP) in re-
sponse to numerous stimuli [2–5], including hemoglobin oxygen saturation (SO2) [6]. Follow-
ing release, ATP binds to purinergic receptors on capillary endothelial cells which conduct
an electrical response to upstream arterioles, leading to their vasodilation [7]. Therefore,
RBCs are believed to play an important role in the local regulation of oxygen (O2) distri-
bution through the SO2-dependent release of ATP [8, 9].
In addition to its importance in regulatory physiology, SO2-dependent ATP release has been
shown to be impaired in many cardiovascular diseases such as sepsis [10], prediabetes [11]
and type II diabetes [12]. In these studies, the amount of ATP released was decreased for
1A version of this chapter has been published in PLOS ONE [1].
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the same stimulus. Therefore, RBCs become a potential screening target for cardiovascular
disorders.
Although SO2-dependent ATP release has been measured, there are currently no studies
that quantify the dynamics of this process. Since ATP release is believed to be involved
in the regulation of O2 distribution, understanding the dynamics is crucial for our under-
standing of the regulatory pathway. The time required for ATP to be released determines
the spatial sensitivity for the RBC to signal to the endothelium changes in their SO2.
The ultimate goal of our research is to develop a cost effective tool to quantify the dynamics
of ATP release from RBCs furthering our ability to characterize the underlying physiology
of blood flow regulation. Various studies in the literature have developed means of control-
ling O2 in microfluidic devices for a variety of applications [13–20], e.g. microfluidic devices
for establishing hypoxia in cell cultures [13]. Many of these studies apply mathematical
modelling to verify that they are correctly maintaining their target O2 levels [14–16, 18, 19].
In an earlier study, we employed a novel micro-delivery approach to change local oxygen
levels in vivo [21, 22]. We also previously described a computational model of an idealized
microfluidic device to measure the dynamics of SO2-dependent ATP release in vitro [23].
The objective of the design was to create a spatial step change in SO2 in a steady flow-
ing channel, then measure the corresponding ATP released from the RBCs. The resulting
spatial information can then be translated into temporal. This approach was adapted from
Wan et al [24], and is described in detail in our previous study [23]. In contrast to other
devices for controlling oxygen, our application is intended to spatially control the O2 con-
tent of flowing RBCs.
Although the previous model predicted that the device was able to create a sufficient drop
in O2, the idealized microfluidic device was not practical to fabricate using common soft
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lithography techniques. This motivated a new device design that is both practical and
functional. However, the complex geometric design of the new device and the use of O2-
permeable materials makes predicting the SO2 of the RBCs more difficult. Therefore, in
this study we develop a 3D computational model of the new device, in order to optimize the
dimensions, and to ensure that O2 characteristics in the device are sufficient for quantifying
the dynamics of SO2-dependent ATP release. Additionally, this model will be crucial to aid
in the analysis of results of subsequent studies using this design.
4.2 Methods
In this work, we take a computational approach to design a device for measuring the dy-
namics of SO2-dependent ATP release from RBCs. We propose a device that consists of two
parts (see Fig 4.1), the first part being a microfluidic channel fabricated in PDMS using soft
lithography techniques. This channel will be embedded in PDMS using a mould, and sealed
with a PDMS spin coating technique. The second part being a large oxygen-impermeable
gas flow channel with a window to allow gas exchange between the two channels. The
two parts are aligned orthogonal to each other with the gas exchange window centred at
their intersection. The bottom channel is designed to deliver a gas with a low concentra-
tion of oxygen, whereas the top microfluidic channel will deliver fully oxygen-saturated red
blood cells suspended in a physiological buffer. The large gradient in oxygen partial pres-
sure at the exchange window between the two channels drives the desaturation of the RBCs.
In the present work, we will explore the influence of geometry on the device’s ability to
control the oxygen levels the cells are exposed to using a computational model of fluid
dynamics and mass transfer (kinetics of ATP release and reaction with luciferin/luciferase
will be simulated in a subsequent model); see Fig 4.1 for the geometry. Due to the large
number of geometric parameters we can vary, we start by analyzing a 1D analytic model of
oxygen exchange to guide our choice of parameters to vary with the 3D model.
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Figure 4.1: Device Design Diagram of x-normal (left) and z-normal (right) views of the RBC
channel and exchange window. The light blue colour represents PDMS and the grey colour represents
glass.
4.2.1 Analytic Model
The following equation describes the oxygen partial pressure, PO2, of the blood in a mi-
crofluidic device with an exchange window of length Lw centred at x = 0.
D
d2PO2
dx2
− cdPO2
dx
=

k1(PO2 − P0), x ∈
(−∞,−Lw2 )
k1(PO2 − P0) + k2(PO2 − Pl), x ∈
[−Lw2 , Lw2 ]
k1(PO2 − P0), x ∈
(
Lw
2 ,∞
)
(4.1)
with boundary conditions,
lim
x→−∞P (x) = P0 (4.2a)
lim
x→∞P (x) = P0 (4.2b)
whereD is diffusivity of oxygen in plasma, c is the flow velocity, and k1 and k2 are the rates of
oxygen permeation through the walls of the channel and the exchange window respectively;
they depend on the thickness of the PDMS walls and the permeability of PDMS to O2. P0
is the external oxygen partial pressure and Pl is the oxygen partial pressure of the gas in the
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exchange window. The microfluidic device is assumed to be infinitely long so that we can
neglect inlet/outlet effects and the effects of oxygen binding to hemoglobin are neglected in
the model.
Non-Dimensional Analysis
Non-dimensionalization allows us to determine the parameters that effect the behaviour of
the solution. We introduce the following dimensionless parameters: ξ = xLw +
1
2 , v =
PO2−Pl
P0−Pl ,
u = 1− v, Pe = cLwD , S1 = k1L
2
w
D and S2 =
k2L2w
D which gives,
d2u
dξ2
− Pedu
dξ
− S1u =

0, ξ ∈ (−∞, 0)
S2(u+ 1), ξ ∈ [0, 1]
0, ξ ∈ (1,∞)
(4.3)
with homogeneous boundary conditions at infinity. Dimensionless O2 is represented by v
and the dimensionless drop in O2 is represented by u. From the non-dimensionalization, we
see that the behaviour of the solution depends on three independent parameters, Pe, S1 and
S2. Pe is the Peclet number and represents the ratio of convective to diffusive transport. S1
and S2 are dimensionless k1 and k2, respectively. The dimensionless solution for a specific
case is shown in Fig 4.2.
There are three main criteria that we will use to assess the performance of the device. First,
the device must be able to cause a large enough change in O2 to elicit ATP release from
the RBCs. This first criterion can be quantified by taking the maximum drop in PO2. Eq
4.4 gives this criterion in terms of the 1D model parameters,
∆PO2max = (P0 − Pl)umax (4.4)
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Figure 4.2: Dimensionless Solution Solution to the 1D dimensionless model. The dimensionless
O2, v, is shown as a function of dimensionless position, ξ for Pe = 10, S1 = 5 and S2 = 20. The
exchange window is between 0 and 1. The red arrow indicates ∆ξ = 1.04 with umax of 0.68. For
this set of conditions, dimensionless O2 begins to fall just before the window and continues to fall
across the length of the window before beginning to rise.
where umax is the maximum value of u(ξ).
Second, the drop in O2 must be sufficiently rapid to resolve the dynamics of ATP release.
This can be quantified as the amount of time between the maximum and the minimum
PO2. Since this time depends on ∆PO2max , we normalize it with respect the drop. This
criterion is a representation of the rate of O2 drop. Eq 4.5 gives the second criterion in
terms of the 1D model parameters,
∆PO2max
∆t
=
c(P0 − Pl)
L
umax
∆ξ
(4.5)
where ∆ξ is the change in dimensionless position between when the maximum and mini-
mum value of u(ξ) deviate by 1% of their original values.
Third, the temporal resolution of the system has to be able to resolve the dynamics. This
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can be quantified in terms of the spatial resolution, , of the system and the flow velocity,
c, as τ = c .
Parameter Selection
To select the ideal parameters for the 1D model, we optimize our three performance cri-
teria. The parameters involved are the physical parameters (P0 − Pl), c, and L and the
dimensionless parameters umax and ∆ξ, which are dependent on Pe, S1 and S2. In or-
der to maximize the maximum drop in PO2, umax has to be maximized. Fig 4.3 shows
umax as a function of Pe for different values of S1 and S2. From Fig 4.3, umax is maximized
as Pe→ 0, S1 → 0 and S2 →∞. As S2 increases, umax becomes less sensitive to S1 and Pe.
Peclet Number
0 5 10 15 20 25
M
ax
im
um
D
im
en
sio
nl
es
s
O
2
D
ro
p
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
S2 = 80
S2 = 20
S2 = 5
S1 = 1
S1 = 5
S1 = 10
Figure 4.3: Dimensionless O2 Drop The maximum dimensionless O2 drop, umax, as a function
of Pe´clet number, Pe. The solid, dashed and dot-dashed curves represent S1 values of 1, 5 and 10,
respectively. The red, black and blue curves represent values of S2 of 5, 20 and 80 respectively.
In order to maximize the rate of O2 drop, umax/∆ξ should be maximized. Fig 4.4 shows
umax/∆ξ as a function of Pe for varying values of S1 and S2. From Fig 4.4, umax/∆ξ is
maximized for large Pe, small S1, and large S2. The effect of S2 on O2 drop rate is larger
than that of S1.
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Figure 4.4: Dimensionless Drop Rate The dimensionless rate of O2, umax/∆ξ, as a function
of the Pe´clet number, Pe. The solid, dashed and dot-dashed curves represent S1 values of 1, 5 and
10, respectively. The red, black and blue curves represent values of S2 of 5, 20 and 80 respectively.
To optimize both umax and umax/∆ξ a compromise in Pe must be chosen since umax is
maximized for small Pe and umax/∆ξ is maximized for large Pe. However, since the effects
of Pe on umax are small for large S2, if we can choose large S2, we can choose the Pe to
satisfy the optimization of umax/∆ξ.
Since we cannot control diffusivity, the dimensionless parameters must be controlled by
altering c, L, k1 and k2. To minimize S1, k1 should be as small as practical; physically this
can be achieved by making the walls as thick as possible. To maximize S2, k2 should be
made as large as possible; this can be achieved by making the spin coat layer as small as
possible. (P0 − Pl) should also be made as large as practical.
The flow velocity, c, affects Pe, ∆PO2max/∆t and the temporal resolution, τ . All three
parameters are optimized with a larger c. The effect of window length, Lw, is less straight-
forward since it effects the dimensionless parameters and ∆PO2max/∆t. S1 and S2 are
sensitive to Lw since they are related quadratically, and since they have opposite optima,
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care must be taken while choosing the length of the exchange window. The effect of the
window length will be explored with the 3D model.
4.2.2 Computational Model
Mesh Generation
The geometry construction and mesh generation were performed using the open source soft-
ware GMSH [25]. The same mesh was used for both the fluid dynamics simulations and the
mass transfer simulations.
For each geometry, a hybrid mesh was used, with structured regions in the flow channels and
an unstructured region in the PDMS area (which is far from the region of interest) to reduce
the number of elements. Element sizes were decreased until the solution no longer changed
with mesh resolution. The resulting meshes varied between simulations, but typically the
smallest elements (located in the RBC channel) were on the order of 0.01 mm, and the
largest elements (located in the PDMS) were 0.5-1.0 mm.
Fluid Dynamics Simulations
The flow in both channels were assumed to be Newtonian, incompressible and isothermal.
The blood was assumed to be a single homogeneous fluid. The resulting steady-state equa-
tions for flow in both channels are given by:
∇ · ~vi = 0 (4.6a)
ρi~vi · ∇~vi = µi∇2~vi −∇p (4.6b)
where ~vi, ρi, µi are the velocity, density and dynamic viscosity of the fluid respectively
and p is the hydrodynamic pressure in the fluid. The subscripts i = g, p, rbc refer to the
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gas, plasma and red blood cells. Since the blood is assumed to be homogeneous ~vp = ~vrbc,
ρp = ρrbc and µp = µrbc.
Eq 4.6a and 4.6b were solved numerically using open source software OpenFOAM [26].
The software discretizes the equations using a finite volume method and solves the coupled
system of equations using the Semi-Implicit Method for Pressure Linked Equations [27].
Mass Transfer Simulations
The following equations were used to model the oxygen transport throughout the microflu-
idic device [28]:
Dpdmskpdms∇2PO2 = 0 ∈ Ωpdms (4.7a)
kg~vg · ∇PO2 = Dgkg∇2PO2 ∈ Ωg (4.7b)[
(1−Ht)kp~vp +Ht
(
krbc + [HbT ]
dSO2
dPO2
)
~vrbc
]
· ∇PO2 =
Dpkp∇2PO2 ∈ Ωrbc (4.7c)
where Di, ki, PO2, Ht, and [HbT ] are the diffusivity, solubility, oxygen partial pressure,
hematocrit and total heme concentration of the blood respectively. The different regions
of the device are designated by Ωj , where the subscripts j = pdms, g, rbc, p represent the
PDMS, gas, red blood cells and plasma respectively. The derivative dSO2dPO2 can be found
from the Hill equation [29]:
SO2 =
PON2
PN50 + PO
N
2
(4.8)
where SO2 is hemoglobin oxygen saturation, N is the Hill coefficient and P50 is the partial
pressure of oxygen at 50% saturation.
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Eqs 4.7a-c were discretized using in-house software that utilizes a stabilized Galerkin finite
element method programmed in C++; a least squares stabilizer was used in the convective
regions of the domain [30]. The resulting non-linear system of equations were iteratively
linearized and solved with the Generalized Minimal Residual Method [31]. Convergence
was verified for the extreme cases by refining the mesh to be sure that the solution was in-
dependent of the choice of discretization. All simulations were run on a personal computer
with an 8 core 4.2 GHz processor with 16 GB of RAM. Simulation times were less than an
hour on one core.
To quantify the O2 exchange in the 3D model we define the weighted drop in PO2 by the
following,
WD = maxPO2∈x
1
Wr
∫ z=Wr
2
z=−Wr
2
∫ y=y0+Hr
y=y0
PO2(x, y, z)e
−µ(y−y0)dydz (4.9)
where Wr and Hr are the width and height of the RBC channel, respectively, y0 is the
location of the bottom of the channel and µ is the optical attenuation of blood plasma.
This is a weighted integral of the PO2 along the depth of the channel (y-direction) to give
a stronger weighting to the PO2 values closer to the bottom of the channel since that is
where the detector will be located. It is then averaged across the width of the channel
(z-direction) and the maximum value is taken along the stream-wise direction (x-direction).
The spatial drop time is quantified in the same way as for the 1D model; the 3D profile is
reduced to one dimension by using the same weighted integral in y and taking the centreline
in z.
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4.3 Results
To investigate the effects of 3D geometric features, we simulated the O2 transport in the
microfluidic device for various dimensions of the RBC channel. In particular, we varied
cross-sectional area of the RBC channel, as well as its aspect ratio to capture the effects
of channel cross-section. In addition, we varied the length of the exchange window to de-
termine how the O2 drop and its rate are affected. We also varied spin-coat thickness to
determine how important it is for our particular geometry and physical conditions. Fig 4.5
shows a specific solution of the 3D model using the parameters in Table 4.1; this figure
shows the weighted centreline profile.
Parameter Value
Baseline Oxygen Partial Pressure (mmHg) 160
Gas Oxygen Partial Pressure (mmHg) 0
Diffusivity of Oxygen in Nitrogen (mm2/s) 17.6
Solubility of Oxygen in Nitrogen (µM/mmHg) 5.342105
Solubility of Oyxgen in RBCs (µM/mmHg) 1.47
Diffusivity of Oxygen in Plasma (mm2/s) 0.00275
Solubility of Oxygen in Plasma (µM/mmHg) 1.33
Diffusivity of Oxygen in PDMS (mm2/s) 0.00355
Solubility of Oxygen in PDMS (µM/mmHg) 17.959
Total Heme Concentration (µM) 5350
Oxygen Partial Pressure at 50 % Saturation (mmHg) 37
Hill Coefficient 2.7
Hematocrit 0.1
Table 4.1: Model Parameters
First, the cross-sectional area of the RBC channel was varied maintaining a constant mean
velocity. The channels simulated were square in cross-section ranging from 100x100 µm2
to 500x500 µm2. The maximum drop in PO2 increased with increasing cross-sectional area
(see Fig 4.6). This appears to be due to the increased surface area for exchange as well as
the increased volume in the channel contributing to the weighted drop. In contrast, rate
of drop decreases with area. This is likely due to the increasing volume of the RBC channel.
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Figure 4.5: Solution to the 3D model The top left colormap shows the y-normal plane close
to the bottom edge of the channel (y = 0.5775). The bottom left colormap shows the z-normal plane
through the center of the geometry. The colormap on the top right shows the x-normal plane through
the center of the geometry. The white dashed line indicates the RBC channel. The plot in the bottom
right shows the weighted centreline drop in PO2. The black dashed line indicates the location of the
exchange window.
From Fig 4.7, channels with smaller height to width ratio perform better at dropping the
O2 compared to short, wide channels of the same area. This is due to multiple factors: first,
the channels that are taller have more volume contributing to the weighted drop (see Eq
4.9). Second, the taller channels are thin, allowing the more surface area on their sides to
be exposed to low O2. Fig 4.8 shows colour maps for the two extreme cases. The change in
drop rate follows the same trend as with the weighted drop.
Increasing the length of the window causes an increased drop in PO2 and an increased drop
rate (see Fig 4.9). The increase in PO2 drop can be explained by having a longer window,
exposing more of the channel to low O2.
Increasing the spin-coat layer thickness causes a decrease in the drop in PO2; this relation-
ship is approximately linear. The change in drop rate follows a similar trend to the drop
in O2 (see Fig 4.10). In terms of the 1D model, increasing the spin-coat thickness increases
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Figure 4.6: Effect of RBC Channel Cross Sectional Area The weighted O2 drop (blue)
and weighted O2 drop rate (red) as a function of RBC channel cross-sectional Area. The channels
simulated are square in cross-section.
S2, which causes a smaller drop in O2 and a smaller drop rate (see Figs 4.3 and 4.4); this
trend agrees with our 3D results. Hematocrit has negligible effect on both the weighted
drop and the drop rate (Fig 4.11).
4.4 Discussion
Ellsworth et al suggested that ATP release time is less than 500 milliseconds [32] based
on the RBC transit time in an isolated arteriole preparation exposed to low oxygen levels.
Based on this estimate, we require a system with a resolution on the order of milliseconds.
Wan et al measured shear-dependent ATP release time and reports it to be on the order of
25-75 milliseconds [24]. If the mechanisms responsible for ATP release are similar for both
shear-dependent and O2-dependent release, then we expect, ATP release time to be similar
to the value measured in their study. Understanding the time course for ATP release from
RBCs is important since it determines where in the vasculature ATP is released and where
the vessels will sense ATP. Further, many inflammatory diseases have been associated with
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Figure 4.7: Effect of RBC Channel Aspect Ratio The weighted O2 drop (blue) and weighted
O2 drop rate (red) as a function of RBC channel aspect ratio (width:height). The area of the channels
simulated was held constant (0.15 mm2).
impaired ATP release, thus a measurement of ATP release dynamics could be used to screen
for these diseases.
In previous work, we showed the feasibility of using steady-state flow to measure the dy-
namics of SO2-dependent ATP release in vitro [23]. This work was based on an ideal device
in order to test the viability of the concept. We demonstrated two important design criteria,
first, that the device was able to cause a sufficient drop in O2 and second, that we were
able to recover time-dependent changes in the ATP signal. Although this study was able
to show the feasibility of our device, the idealized design described in this article was not
practical to fabricate.
With the practical considerations in mind, we developed a simple 1D model of oxygen trans-
port in our device in order to qualitatively evaluate some of the simulation parameters to
reduce the number of simulations required to determine the optimal design for our appli-
cation. The 1D model is an idealization of the device and does not account for geometric
information such as the RBC channel’s cross-section dimensions, though some of the ge-
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Figure 4.8: Simulation of RBC Channel Aspect Ratios The PO2 solution showing the x-
normal plane through the center of the geometry for two different aspect ratios. The colormap on
the top shows the simulation results for a channel with 1:5 width to height ratio. The colormap on
the bottom shows the simulation results for a channel with a 5:1 width to height ratio. The white
dashed line indicates the RBC channel.
ometric information is embedded in the model parameters, such as PDMS thickness. To
compare the performance of the 1D model against our 3D simulations, we show the weighted
O2 drop predicted by the 1D model for varying exchange window lengths and PDMS spin
coat thicknesses (see Fig. 4.12).
The 1D model predicts the O2 drop to level off and reach a steady value as the exchange
window length increases. The 3D model predicts the O2 drop to increase with increasing
window length, though for the parameters used, the simulation results do not reach a steady
drop. Further, the value of the drop is considerably lower than predicted by the 1D model.
Considering the PDMS spin coat thickness, the 1D model predicts the O2 drop to approach
zero as the thickness increases; the O2 drop is predicted to approach the maximum drop as
the thickness approaches zero. Comparing these results to the 3D simulations, the O2 drop
is substantially lower than predicted by the 1D model and does not begin to level off for
the lowest thickness simulated. While the 1D model predictions appear reasonable, the O2
drop is overestimated compared to the 3D model and is more sensitive to the variations in
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Figure 4.9: Effect of Exchange Window Length The weighted O2 drop (blue) and weighted
O2 drop rate (red) as a function of exchange window length.
the geometric parameters.
The 1D model approaches the 3D model as the RBC channel becomes infinitely wide and
its height becomes infinitesimally small. It assumes cross-stream diffusion in the RBC flow
is negligible and diffusion in the PDMS occurs only vertically. Further, the 1D model also
assumes that the fluid velocity in the gas channel is infinite, so that the low oxygen is main-
tained at the gas channel side of the exchange surface. Due to these simplifications, the
1D model overestimates the drop in O2; these simplifications also account for the increased
sensitivity of the geometric parameters. Although the 1D model does not accurately ac-
count for the O2 content in the device, it allows us to qualitatively determine the behaviour
of changing certain parameters. Also, since the model can be solved analytically, we can
simulate a large range and achieve practically continuous information. Therefore, the 1D
analytical model is a useful tool for qualitatively understanding the physical details of our
system, but a 3D model is required to quantify the extent of the behaviour.
Though the 1D model was useful in helping us determine how the O2-permeable walls will
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Figure 4.10: Effect of Spin Coat Thickness The weighted O2 drop (blue) and weighted O2 drop
rate (red) as a function of PDMS spin-coat thickness.
affect the O2 exchange, it fails to capture some of the important 3D features. Thus, we
used a 3D model to explore how the O2 exchange is affected when we have a channel of
finite cross-section and diffusion around the sides of the RBC channel from the exchange
window and outside surfaces.
The first 3D aspect of the device geometry we look at is the RBC channel’s cross-section.
From Fig 4.6, it is clear that there is an optimal cross-sectional area. Channels with larger
cross-sectional areas have larger surface areas, leading to more area for the exchange. How-
ever, the exchange is limited to the lower walls of the channel since the exchange window
is on the bottom. For the larger channels, the width of the window limits how much of the
side walls’ surface area is exposed to the low levels of O2. If we now allow the channel to
increase in surface area, but not get any wider, we can optimize the amount of surface area
exposed to the low levels of oxygen; this is demonstrated in Figs 4.7 and 4.8. In contrast
our previous results showed channels that are less deep are more beneficial since the drop
extends across the whole channel [23]. However, this was because the 2D model in [23]
assumes that the channel and window are infinitely wide; thus, it neglects the effect of low
oxygen on the sides of the channel.
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Figure 4.11: Effect of Hematocrit The weighted O2 drop (black bars) and weighted O2 drop rate
(white bars) for 0% and 20% hematocrit. A negligible effect is shown for both.
Figure 4.12: 1D Model Prediction of Geometric Parameters Weighted O2 drop was sim-
ulated using the 1D model to determine the effect of varying exchange window length (left) and
PDMS spin-coat thickness (right). The inset in the right panel shows the parameter range used in
the 3D simulations. The results of the simulations were re-dimensionlized in order to be comparable
to the 3D simulation results (see Fig. 4.9 and 4.10). Note: the parameters range used in the 3D
simulations for the exchange window length was 0.1-1.
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In the 1D model, the length of the window is the characteristic length. Thus it not only
effects O2 exchange through Equation 4.5, but it also effects umax and umax/∆ξ through
the dimensionless parameters. From Fig 4.9, we see that having a longer window is better
for both the drop and the drop rate of O2. The benefits of longer windows will become less
important as O2 in the channel approaches zero. Practically, a very large exchange window
will result in a structurally weak device; the thin PDMS layer separating the RBC and gas
channel may rupture or deform. Therefore, the exchange window should be large enough
to cause a sufficient drop in oxygen, but not so long that the device becomes structurally
compromised.
The 1D model indicates that the ideal device would have an infinitely thin spin-coat layer.
However, practically, we need a barrier that closes the RBC channel so that it does not
leak; thus it has to be thick enough so that it does not rupture under the pressure of the
flow. Physically, we can fabricate spin-coat thicknesses on the order of 20 µm and these
channels do not rupture under the pressure of the flow. From Fig 4.10, we can see that in
the range of practical spin-coat sizes (20-100 µm), the spin-coat thickness does not affect
the O2 exchange substantially. Therefore, small variability in the thickness of the spin coat
layer will not affect the effectiveness of the device.
Interestingly, hematocrit has only a small effect on the O2 exchange in our device. From
Fig 4.11, we can see that lower hematocrit is better for exchange, though, the change is
not large. An important point to consider is that larger hematocrit will result in more
RBCs available to release ATP, increasing the amount of signal coming form the system.
However, the amount of RBCs affects the optics of the system since they absorb visible
light. Therefore, we should use a hematocrit that is large enough to attain a measurable
ATP signal, but not so large that all the signal is attenuated by the cells. We considered
this effect in a previous study [23].
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In this study, we did not simulate every possible geometric parameter, such as the length
of the RBC channel, the height of the PDMS around the channel, the width of the window,
and the dimensions of the gas channel. We no not expect the length of the RBC channel to
be too important for exchange. For the purposes of the analysis of the experimental results,
the flow should be fully developed. Therefore the channel should be longer than the en-
trance length, though at the flow rates typically used in microfluidics, the entrance lengths
are quite small (on the order of 3-30 µm). As for oxygen exchange in shorter channels, the
drop will be smaller since the source of oxygen is closer to the exchange window. This will
also result in a steeper rate. However, these effects are only important for channels on the
order of the entrance length.
Practically, the exchange window cannot exceed a width of 1 mm due to the risk of the
PDMS spin-coat deforming into the window causing distortion to the optical image. Intu-
itively, wider windows will improve exchange since there will be more area for exchange,
though the effect will become insignificant as the window becomes much wider than the
channel. From the 1D model, we expect more PDMS around the RBC channel to be bet-
ter as this decreases the effective permeability of the walls. However, if there is too much
PDMS above the channel, there may be optical problems.
This study focuses on the ability of the proposed microfluidic device to cause a drop of
PO2 in a flowing RBC suspension. However, the main goal of this device is to measure the
release of ATP from RBCs in response to their SO2. The relationship between PO2 and
SO2 is modelled by the Hill equations (Equation 4.8). Fig 4.13 shows the Hill equation for
human RBCs. This figure demonstrates that for low and high PO2, large changes in PO2
are required to change saturation. In contrast, in the mid-range of PO2, only small changes
in PO2 are required to produce large changes in SO2. Since the RBCs in our simulation
span PO2 values from zero to 160, we expect our device to almost fully desaturate the RBCs.
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Figure 4.13: Hemoglobin Binding Curve Hemoglobin oxygen saturation as a function of partial
pressure determined by the Hill equation.
The ideal device should have a low width to height ratio with a large area such that the
width of the channel is much less than that of the exchange window. The device should
have a spin-coat layer that is thin as possible, while still being able to withstand the flow
pressure The exchange window should be long enough, but not so long that though it that
the spin-coat layer sinks into the window. The hematocrit should be chosen to get a large
enough signal from the ATP but small enough to not lose light from attenuation. The
weighted centreline PO2 and SO2 drop are shown in Fig 4.14.
Microfluidic devices have become increasingly popular for use in biological studies due to
their reduced sample consumption, relative low costs and length scales that are comparable
to dimensions on the cellular level. Microfluidic devices are used in a wide range of biological
applications including hemodynamics at the microvascular scale [33–35] and cell behaviour
under shear stress [24, 36, 37]. Microfluidic devices can be used to establish gradients of
small molecules [38–41]. Further, in recent years, microfluidic devices have been used to cre-
ate micro-scale cell cultures that mimic in vivo micro-environments to study physiological
tissue interactions [42–45]. Due to their vast applications in biological settings, microfluidic
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Figure 4.14: Simulation of Ideal Design The ideal device was simulated with channel height
of 0.5 mm and width of 0.3 mm, a 0.02 mm spin coat and a 1 mm long exchange window. This
figure shows the weighted centreline drop in PO2 (blue) and the weighted centreline SO2 (red) as
a function of position along the RBC channel. The black dashed line indicates the location of the
exchange window.
devices must be designed to meet the oxygen requirements of the study. Living cells are
highly sensitive to the oxygen levels in their environment and may behave irregularly when
exposed to unphysiological levels [46–48]. And since the results of our study demonstrate
the crucial role that geometry can play in oxygen transport, it is an important consideration
for the design of microfluidic channels. Our methods can also be applied to other gases and
solutes as well as temperature.
Various studies have implemented mathematical models in order to validate and optimize
microfluidic designs [14–16, 18, 19]. In these studies, the use of mathematical modelling
was necessary for ensuring the proper distribution of oxygen in their application. Some
of these studies considered only 2D models of their devices [14–16], while others used 3D
models [18, 19]. In the studies that employed 2D models, 2D geometry was often sufficient
to approximate the overall transport due to inherent symmetries in the device. In our
application, a 3D geometry was crucial for two reasons. First, our device possessed two
stream-wise directions (gas flow direction and RBC flow direction). Further a 2D model
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would not allow us to vary parameters that lay orthogonal to the plane that was being
modelled.
In conclusion, although the 1D model provided important qualitative insights, the 3D model
demonstrated that diffusion through the PDMS surrounding the RBC channel yielded un-
expected relationships important to the design of the device. Thus the use of a 3D transport
model is crucial for guiding our optimal design.
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Chapter 5
Using digital inpainting to estimate
incident light intensity for the
calculation of red blood cell oxygen
saturation from microscopy
images1
5.1 Introduction
Adequate oxygen supply is crucial to the proper functioning of most tissues in the body,
and therefore blood oxygenation is an important indicator of tissue function. For instance,
measurements of blood oxygenation have implications for the study of pre-diabetes [1] and
sepsis [2–4]. Red blood cells (RBCs) are the primary carriers of oxygen (O2) in the circula-
tory system, accounting for approximately 98% of the O2 carried in the blood [5]. Due to
the low solubility of O2 in blood plasma, O2 binds with high affinity to the vast quantity
of hemoglobin in RBCs. Since most of the O2 in the blood is bound to the hemoglobin in
RBCs, hemoglobin oxygen saturation (SO2) is an appropriate measure of O2 content in the
blood [5].
1A version of this chapter has been accepted to the Journal of Biophotonics.
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Advances in the accuracy and ease of SO2 measurements were made when it was recognized
that a second, oxygen-independent wavelength could be used to calibrate SO2 measure-
ments, without the need to calculate optical path lengths and hematocrit. The proposition
of using a two-wavelength spectroscopic method to measure SO2 was first proposed by
Matthes et al. [6] in 1935, who built an apparatus to measure ear SO2 . Since then, many
methods have been developed based on this principle [5, 7–12]. In particular, Ellsworth et
al., 1987 developed a computer-based approach for measuring SO2 of a single RBC flowing
through capillaries in live in vivo experiments by using the light intensity measurements
along the centerline of vessels. This method was improved by Ellis et al. [11, 13] to allow for
simultaneous image acquisition at both wavelengths by introducing a second video camera.
Further advances were made by Japee et al., 2005 [12], who extended the analysis to full
frame images, instead of being limited to single pixel line. Many recent animal studies have
relied on these methods to make measurements of SO2 [1, 4, 14–17].
Theoretically, dual-wavelength SO2 measurements are calculated from the ratio of optical
densities between two wavelengths, as outlined in Ellsworth 1987 [5]. The optical densities
can be calculated from:
OD = log10
(
I0
I
)
, (5.1)
where I is the light intensity that was transmitted through the RBCs and I0 is the incident
light. Therefore, SO2 calculations require not only the measured light intensities, I, at
two wavelengths, but also the incident light, I0, at both wavelengths. Previous researchers
[5, 11, 13] have estimated I0 by using video data to measure the light intensity of the plasma
gaps between the RBCs as they travel single file through the capillary. As the RBCs move
out of the way, the plasma intensity gives the intensity of the pixels behind the RBC. This
can be accomplished algorithmically by calculating the maximum intensity, Imax at each
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pixel over a specified number of frames, since RBCs absorb more light, and thus have lower
intensity values than the plasma. In a maximum intensity image, moving RBCs disappear
[18] revealing the plasma light intensity.
The efficacy of Imax as an approximation for I0 is dependent on RBC velocity, the size of
plasma gaps, as well as camera exposure time. The RBCs must move quickly enough to
show the background tissue, and the plasma gap must be large enough that the camera
captures the background light intensity. If the exposure is too long, the RBC can appear
blurred throughout the plasma gap, artificially decreasing the size of the plasma gap or ab-
sorbing light, thus attenuating I0. Ensuring that Imax captures the incident light intensity
at all pixels is controlled by using an appropriate number of frames, a fast frame rate, and
a short exposure time. However, Imax will fail if there are stationary cells, or if hematocrit
is large enough that there are no plasma gaps. Additionally, if the background varies more
rapidly than the time between I0 estimations, Imax will be a poor estimation of I0; this will
be more problematic when slow RBC velocities require a large number of frames to calculate
Imax. In general, provided we can use a small number of frames, Imax is a good estimation of
I0 for digital cameras with high signal to noise ratio (SNR) under the acquisition conditions.
In this study, we propose an alternate, and complementary method for estimating I0 that
does not suffer from the aforementioned deficiencies, through the use of digital inpainting.
Digital inpainting is an image processing technique used to estimate missing information in
an image. In this paper we demonstrate the use of inpainting to determine the incident light
intensity to calculate SO2. Specifically, we will compare two different inpainting methods
to the method currently employed in the literature to estimate the incident light intensity.
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5.2 Methods
5.2.1 Maximum Intensity Images
The maximum intensity images, Imax, were calculated by determining the maximum inten-
sity of each pixel over a specified number of frames, expressed as a time, ∆t. This method
is modified from methods presented in the literature [5, 11, 18, 19] which approximate I0
as Imax − 3σ, where σ is the standard deviation of the intensity over time. However, the
cost of calculating σ is relatively large, so with the advent of low-noise digital cameras, it
is sufficient to use Imax [1, 4, 14–17].
5.2.2 Inpainting
Digital inpainting is traditionally used to remove unwanted features from images using
global and/or local image information [20–22]. Many inpainting methods are based on
solving partial differential equations (PDEs) using the surrounding pixel intensity values as
fixed-value boundary conditions. Analogies are often made to mass transport in order to
derive the PDE for inpainting. To estimate I0, we considered two inpainting methods, the
first based on diffusion and the second on convection.
Diffusion-Based Inpainting
An inpainting method based on simple diffusion would solve Laplace’s equation with fixed-
value boundary conditions representing steady-state diffusion:
∇2Id0 = 0 ∈ Ω (5.2a)
Id0 = I ∈ ∂Ω , (5.2b)
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where Id0 is the diffusion-based in-painted image, Ω is the inpainting domain, ∂Ω is the
inpainting boundary and I is the original image (see, e.g., [23]).
This equation can be solved numerically using a number of well-known schemes. In this
study, Equation 5.2 was discretized using the second-order central difference scheme, and
the system was then solved using the Gauss-Seidel method with successive over-relaxation.
Inpainting based on simple diffusion has a tendency to blur sharp features, and for this
reason, anisotropic diffusion is often used [22]; these methods use a diffusion coefficient that
depends on the gradient of the image. However, we suspect simple diffusion will perform
sufficiently well when the image has a relatively homogeneous background, which is often
the case for our application.
Convection-Based Inpainting
An inpainting method based on convection would solve:
~c · ∇Ic0 = 0 ∈ Ω (5.3a)
Ic0 = I ∈ ∂Ω , (5.3b)
where Ic0 is the convection-based in-painted image, I is the original image and ~c is a vec-
tor field that dictates the direction of convective transport. For this study, the direction
field was chosen as a modification to the coherence direction of the image as described in
Bornemann and Marz 2007 [24]. Figure 5.1 shows the coherence direction (in white) of a
40x in-vivo microscopy image of capillaries and other microvessels in skeletal muscle.
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Figure 5.1: Modified coherence direction of 40x in-vivo microscopy image of a capillary network in
rat skeletal muscle (extensor digitorum longus).
The modified coherence direction of an image can be calculated from the eigenvector corre-
sponding the smallest eigenvalue of the matrix described by the modified structure tensor
of the image. The modified structure tensor can be calculated as:
J =
Gρ ? (1Γ∇uσ ⊗∇uσ)
Gσ ? 1Γ
(5.4a)
uσ =
Gσ ? (1ΓI)
Gσ ? 1Γ
, (5.4b)
where ? denotes convolution, ⊗ denotes the tensor product, I is the known image intensi-
ties, 1Γ is the indicator function describing the region that has already been inpainted and
Gσ is a Gaussian with mean 0 and standard deviation of σ.
In order to solve this non-linear convection problem rapidly, we discretize and solve the
PDE using a fast-marching scheme as described in various studies [24–26]. A fast-marching
scheme is solved by calculating each point in the domain sequentially following a specified
order. The value at each point, ~x, in the inpainting domain can be calculated by a weighted
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sum of the neighbouring values that have already been calculated,
Ic0(~xk) =
∑
nb
w(~xk, ~xnb)I
c
0(~xnb), (5.5)
where the index k denotes the current node and nb denotes the neighbouring nodes that
have already been in-painted such that |~xnb − ~xk| ≤ ε, where ε dictates the size of the
neighbourhood used in this scheme.
If the order and weighting function are chosen appropriately, one can solve the PDE. We
solved each value in the domain in the order of increasing distance from the boundary. We
chose to use the weighting function described in Bornemann et al., 2007 [24] given by:
w(~x1, ~x2) =
√
pi
2
µ
|~x1 − ~x2| exp
(
− µ
2
2ε2
(
~c⊥(~x1) · (~x1 − ~x2)
)2)
, (5.6)
where µ is a user specified parameter.
Due to the nature of this fast-marching scheme, instead of solving Equation 5.3, the following
PDE is solved:
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~v · ∇Ic0 = 0 ∈ Ω (5.7a)
Ic0 = I ∈ ∂Ω (5.7b)
~c nˆ · ~c > 0
~v =
−~c nˆ · ~c < 0 (5.7c)
nˆ nˆ · ~c = 0 ,
where nˆ is the normal to the boundary, ∂Ω, and ~c is the desired convection field (i.e. the
coherence direction).
If the direction field is parallel to the domain boundary (i.e. nˆ · ~c = 0), the fast-marching
scheme will convect the image information perpendicular to the boundary instead of along
the convection field. For this reason, we exclude parts of the boundary that are parallel to
the convection field in the determination of the distance ordering, as in Marz et al. 2011
[26]. Specifically, we require that:
(nˆ · ~c)2 < γ. (5.8)
For convection inpainting there are five user-specified parameters: ε, σ, ρ, µ and γ. For this
study, unless stated otherwise, we used ε = 15, σ = 2.5, ρ = 10, µ = 20 and γ = 0.2. These
parameters were based on the recommendations in the studies by Ma¨rz [24, 26], modified to
ensure the vector field was parallel to the muscle fibres. The parameters were determined
on different fields of view than the one used for the analyses below. All image intensities
were normalized such that 0 ≤ I ≤ 1.
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5.2.3 Oxygen Saturation Calculation
We calculated SO2 from:
SO2 =
b1 − b2R
a2R− a1 (5.9a)
R =
OD(λ1)
OD(λ2)
(5.9b)
ai = HbO2 (λi)− Hb(λi) (5.9c)
bi = Hb(λi), (5.9d)
where HbO2 and Hb are the extinction coefficients of oxy- and deoxy- hemoglobin at wave-
length λi, respectively.
5.2.4 Image Acquisition
The images used in this study were captured using two QImaging Rolera XR digital cam-
eras attached to the side port of an Olympus XI-81 inverted microscope using a 50/50
beam-splitter to two narrow bandpass filters centred at 442 nm and 454 nm. The images
were taken from an in vivo preparation of rat extensor digitorum longus (EDL) muscle. For
more information on the in vivo preparation, see Fraser et al. 2012 [15].
5.3 Results
Image inpainting was applied to intravital video microscopy images to recover the incident
intensity behind the RBCs. The inpainting domain was constructed by masking out RBCs
using a thresholding technique to locate the RBCs similar to Japee et al. [12, 19]. Figure
5.2 shows the results of inpainting a 40x image. This image was chosen since it is highly
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textured and therefore demonstrates the ability of inpainting to recover local features within
an image. From Figure 5.2, diffusion-based inpainting tends to blur features in the image,
whereas the convection-based approach tends to recover the structures in the image.
Figure 5.2: (A) A single frame from a 40x in vivo capture of rat EDL. (B) Maximum intensity
image calculated over 5 frames (∆t = 0.24 s). (C) Masked regions (in white) indicating the inpainting
domain. (D) Diffusion-based inpainting image. (E) Convection-based inpainting image (ε = 6,
σ = 0.5, ρ = 8, µ = 100 and γ = 0.2).
Ultimately, Imax is sensitive to the number of frames used to calculate the maximum, which
we express as ∆t (the number of frames divided by the frame rate). To demonstrate how
Imax depends on ∆t, we track the pixel intensities of a single pixel within a capillary in a
20x image, as shown in Figure 5.3—this demonstrates that when the time step is too small,
as when ∆t = 0.2 s, Imax sometimes fails to capture the background intensity. However,
as ∆t is increased, Imax also increases, leading to an over-approximation of the background
intensity. To demonstrate the sensitivity of Imax to the fluctuations in the image, we also
track a pixel in a tissue region, as shown in the bottom panel of Figure 5.3.
To compare the effectiveness of inpainting, we calculated the difference between Imax and
the inpainted image on a pixel-by-pixel basis in an example 20x image. However, since Imax
is not the true solution, this does not accurately measure the error in inpainting. To esti-
mate the true error in I0, we inpaint plasma regions that do not have RBCs, and compare
the inpainting solution to the original image. This method is also used to estimate the error
in Imax.
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Figure 5.3: Pixel intensity (black) of a representative pixel in a capillary (top) and the tissue
(bottom) for a 20x in vivo capture of a rat EDL. Imax calculated with 5 (∆t = 0.24 s) and 1050
(∆t = 50 s) frames is shown in blue and red, respectively.
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Figure 5.4 shows the image used to assess the error in I0 (panel A), as well as the masked
RBCs (panel B) and the masked plasma regions (panel C). The RBC masked region consists
of 3675 pixels, and the plasma masked region consists of 2900 pixels.
Figure 5.4: (A) An example 20x in-vivo microscopy image. (B) Masked RBC regions (in white)
indicating the inpainting domain used to calculate I0 behind the RBCs. (C) Masked plasma regions
(in white) indicating the inpainting domain used to determine the error of our I0 calculations.
The error in the different I0 estimations is shown in Figure 5.5. This is plotted over a wide
range of ∆t values, since Imax is sensitive to this parameter. The top panel compares the
inpainted I0 values to Imax, calculated as the absolute value of the difference between the
inpainted region and Imax and then averaged over all pixels. The difference is higher for
very low ∆t since Imax does not remove the RBC. Then, as discussed, after the optimum
∆t, Imax does increasingly worse as ∆t increases.
Thus far, we have compared the inpainting solution to the Imax solution; however, we are
primarily interested in how all three I0 estimates compare to the true I0. To estimate the
true error in the inpainting solution, we estimate I0 within the plasma regions since these
regions do not contain RBCs, and are thus equal to I0. Using the masked plasma region
shown in Figure 5.4C, the error is calculated as the mean of the absolute value of the differ-
ence between the masked regions of an image, and the three estimates of I0 (Imax, I
d
0 and
Ic0), as shown in bottom panel of Figure 5.5. This figure clearly shows the increasing error in
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Imax with ∆t. It also shows that the inpainting methods perform quite well, outperforming
Imax even at small ∆t values. It also appears that convection-based inpainting outperforms
diffusion-based inpainting, as expected, though the difference is surprisingly small.
Figure 5.5: Error estimation for an example image. (Top) Comparison of I0 calculated using
inpainting to the maximum intensity-based, Imax, calculation. Error is calculated as the mean of the
absolute value of the difference between the inpainted image and the Imax image, averaged across all
pixels in the masked region. (Bottom) Comparison of I0 estimates to true I0. The images used were
captured at 21 frames/s.
Histograms of the different pixel errors calculated above are shown in Figure 5.6. Since
Imax is always larger than the true I0, the errors are always negative as shown in the left
panel. For ∆t = 2s and 50s, the average absolute errors are −0.06± 0.03 and −0.13± 0.04,
respectively. For the inpainting methods, both diffusion and convection inpainting have
average absolute errors 0.00± 0.03.
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Figure 5.6: Distribution of errors for the example image shown in Fig 5.4. The distribution of
errors measured as I0 − I˜0, where I˜0 = Imax, Id0 and Ic0. Imax (left) is calculated with 5 (∆t = 0.24
s) and 1050 (∆t = 50 s) frames. Errors are always negative, since Imax over-approximates the
background light intensity. Diffusion (middle) and convection (right) based inpainting methods have
similar errors, and a standard deviation of 0.03.
To relate these errors in I0 to the errors in SO2 measurements, we first express the true
incident intensity, I0, for both wavelengths in terms of the estimated incident intensity, I˜0,
as:
Ii0 = I˜
i
0 + ξi, (5.10)
where the index, i, indicates the wavelength, λi, and ξi is the estimation error.
We can then write the error in saturation as:
Es = SO2 − S˜O2, (5.11)
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where SO2 is the true saturation and S˜O2 is the estimated saturation. The estimated
saturation can be expressed as a function of the I0 errors, ξ1 and ξ2 and the true saturation,
SO2 using Equation 5.9 with the estimated optical density ratio, R˜,
R˜ =
OD(λ1) + log10
(
1− ξ1
I10
)
OD(λ2) + log10
(
1− ξ2
I20
) , (5.12)
where OD(λi) is the true optical density at wavelength, λi, which can be expressed by:
OD(λi) =
(
Hb(λi)(1− SO2) + HbO2 (λi)SO2
)
cx, (5.13)
where c is RBC hemoglobin saturation, x is path length and HbO2 and Hb are the extinc-
tion coefficients of oxy/deoxy-hemoglobin, respectively.
Since the errors in I0 only show up as relative error, and assuming a typical RBC hemoglobin
concentration of 20 mM and a path length of 8 µm, the error in saturation is only a function
of true saturation, SO2, and the relative errors ξˆ1 and ξˆ2, where ξˆi =
ξi
Ii0
. Figure 5.7 shows
a contour plot of the absolute error in SO2 as a function of relative errors in incident in-
tensities at both wavelengths. Since the error in saturation is also dependent on true SO2,
we show the worst case error at SO2 = 0, the best case at SO2 = 1 and a typical case
(SO2 = 0.65).
Finally, we calculated SO2 for individual RBCs using all three methods, as shown in Fig-
ure 5.8. SO2 was calculated as outlined in Section 5.2.3 using the median optical densities
of each cell. The coefficients a1, a2, b1 and b2 were calculated according to Equation 5.9
c-d using the hemoglobin extinction coefficients (λ1 = 442 nm, λ2 = 454 nm) tabulated by
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Figure 5.7: Contour plot of the absolute errors in SO2 as a function of the relative errors in I0,
for three different SO2 values.
Scott Prahl [27].
5.4 Discussion
In this paper, we have applied digital inpainting to estimate the background intensity image,
I0, in order to calculate SO2. We evaluated the accuracy of our I0 estimates by performing
the calculation on regions where I0 was already known. Overall, inpainting was more accu-
rate at estimating I0 than the previous Imax method in most cases, with convection slightly
outperforming diffusion. Though convection-based inpainting outperformed its diffusion-
based counterpart, diffusion-based inpainting is much more straightforward to implement
and is less computationally demanding. The Imax method, however, performs better than
inpainting when the ∆t parameter is sufficiently small since the background intensity is less
likely to vary over short periods of time and there is less chance for outlier noise to appear.
In practice, ∆t values used to measure SO2 typically range from 3 s to 60 s, with a mode of
4 s. In this range of ∆t, inpainting is more accurate than the maximum intensity image for
estimating I0. Further, there are many cases where Imax fails: capillaries with very slow or
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Figure 5.8: Calculated SO2 values for selected in-focus cells, using (A) I˜0 = Imax (∆t ≈ 4 s), (B)
I˜0 = I
d
0 and (C) I˜0 = I
c
0. The top half of the figure shows the SO2 overlaid on top of the original
image. The bottom half shows the distribution of the SO2 values.
stopped flow and vessels with high hematocrit are not able to be analyzed. Additionally,
in some instances, long exposure times are required to collect enough light to visualize the
tissue; this results in an attenuated approximation of I0 using the maximum intensity based
estimation. In all of these cases, digital inpainting can be used to estimate I0 since it is not
dependent on temporal data. However, though inpainting methods can correctly recover I0
for long exposure times, the resulting SO2 would not be correct if the RBC of interest is
blurred due to motion since the estimated intensity of the RBC would be larger than the
true intensity.
Based on the errors in our I0 estimation, we can predict what the errors in SO2 will be.
Figure 5.7 shows that SO2 error is more sensitive to positive errors than negative errors.
Thus since our Imax estimation always over-approximates I0, errors in SO2 are less sensitive
to errors in Imax. The errors in I0 for the inpainting methods are symmetric about zero,
though they have a very low standard deviation, thus the resulting errors in saturation are
low. It is interesting to note that the errors are saturation dependent, with SO2 errors
being more sensitive to errors in I0 at low SO2. However, SO2 values close to zero are
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rarely seen in-vivo. Although not explicitly shown, the errors in SO2 are also dependent
on the wavelengths chosen. If we chose one wavelength (λ2) to be isosbestic, then the error
in SO2 is inversely proportional to the difference in the extinction coefficient of oxy- and
deoxy-hemoglobin. Therefore, choosing a wavelength such that there is a large difference
in extinction coefficients would result in an SO2 error that is less sensitive to errors in I0
estimation. It is important to note that we presented the results for only one representative
image as a demonstration of the use on inpainting to estimate incident light. Inclusion of
more images would be necessary to generalize our inferences.
Additionally, we calculated SO2 values on a cell-by-cell basis using each of the three meth-
ods. All three I0 estimations give comparable SO2 values, though there is a larger range of
SO2 values from the Imax approach. In practice, rather than using extinction coefficients
to calculate the SO2 coefficients, we can calculate the coefficients using data from RBCs
with known SO2 values. This improves the performance of the Imax-based approach since
the calibration values account for the over-approximation in Imax. This is not required for
inpainting since the inpainting approach does not systematically overestimate I0.
One factor to consider in inpainting is that it requires a defined inpainting region. The
size and shape of the RBC mask may influence the inpainting solution since PDEs are
highly sensitive to geometry. For diffusion-based inpainting, the solution is an average of
the boundary propagated inward equally from every direction. This property makes the
diffusion-based approach sensitive to the location of the boundaries. For example, in some
images the capillaries have a brighter intensity than the surrounding tissue. In this exam-
ple, an inpainting boundary that is fully contained within the capillary will outperform an
inpainting boundary that extends into the sounding tissue. The convection-based approach
is less sensitive to this phenomenon since pixel information convects along the coherence
directions. In our images, the coherence directions run parallel to the muscle fibres, pre-
venting the transport of information from the tissue into the capillary.
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Though the convection inpainting scheme used in this manuscript is not overly sensitive to
the masked region, the method does involve a number of free parameters (ε, σ, ρ, µ and γ).
These may affect the accuracy of our I0 estimation. The ε parameter dictates how many
points the scheme uses to calculate the value at each point in the domain, which influences
how well the scheme can accurately represent the direction of the convection. For exam-
ple, a convection direction that is perpendicular to the boundary requires only one point,
where as small angles to the boundary require more. The σ and ρ parameters dictate the
calculation of the coherence direction; σ determines how sensitive the coherence directions
are to changes in intensity and ρ determines the sensitivity to variations in the gradient.
Images with a large amount of noise should choose large σ values. For our application, we
chose large ρ values to ensure that the coherence direction only follows the larger features.
The µ parameter dictates how much diffusion is allowed; as µ→∞, the artificial diffusion
goes to zero. Artificial diffusion ensures that the solution is continuous when the coherence
direction is not well-defined (i.e. in the center of the domain). The γ parameter dictates
which portions of the boundary are allowed to convect information into the boundary. For
our application, we know that the large features are muscle fibres that run parallel along
capillaries, thus we chose a large γ to ensure that the convection only comes along muscle
fibres. In this work, the parameters were not chosen to minimize the error in I0, though an
optimization could potentially be done to yield better results.
In this study, we only considered two possible inpainting algorithms, though there are nu-
merous other possible schemes in the literature. Another common PDE-based example is
anisotropic diffusion-based inpainting, which uses a diffusion coefficient that is inversely
proportional to the image gradient [22]. This type of scheme yields similar results to a con-
vection based approach, which can be seen by expanding the anisotropic diffusion equation
(see Equation 5.14). There also exists texture-based inpainting approaches which attempt
to preserve the texture of an image throughout the inpainting domain; an example of
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texture-based inpainting is described in [28]. Additionally, there have been advances in ma-
chine learning algorithms to determine inpainting domains. For instance, blind inpainting
determines which regions to inpaint based on their different texture from the background
[29]. Such an algorithm could allow for automatic detection of all RBC regions in the tissue.
∇ ·
(
D(Iad0 )∇Iad0
)
= 0 (5.14a)
∇D(Iad0 ) · ∇Iad0 +D(Iad0 )∇2Iad0 = 0 (5.14b)
~c · ∇Iad0 +D(Iad0 )∇2Iad0 = 0 (5.14c)
~c = ∇D(Iad0 ) (5.14d)
Inpainting techniques have also been applied to many different biological applications. For
example, they can be used to create 3D a reconstruction of MRI images from 2D slices [30],
to pre-process MRI images to help with registration [31, 32], in vascular reconstruction [33]
and to help analyze cDNA microarrays [34].
Despite the many benefits of using digital inpainting to recover I0, there are some draw-
backs. First, inpainting is more computationally demanding than the Imax method with
convection being more demanding than diffusion. Second, inpainting requires a separate
algorithm for determining the locations of the RBCs, making it more difficult to automate.
If computational resources are an issue, one could implement a hybrid approach that uses
digital inpainting when the Imax methods fails or when a higher resolution of I0 is required.
Overall, digital inpainting is a method for restoring images that is beginning to be applied
to biological applications. In this study, we have tested whether digital inpainting can
be used to improve dual-wavelength SO2 measurements, by providing a better estimate of
background light intensity. We have found that inpainting is a viable method for calculat-
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ing I0, and that it is often more accurate than the common Imax method. In addition to
outperforming Imax in most cases, it succeeds in cases where the traditional Imax algorithm
fails, such as for stopped or slow moving cells, capillaries with high hematocrit or rapidly
changing background intensities. Additionally, since inpainting allows I0 to be calculated
for each individual frame, inpainting allows for a higher temporal resolution of the back-
ground intensity than Imax. Taken together these improvements in I0 estimation represent
a major advance for spectrophotometric measurement of red blood cell SO2 in intravital
video applications.
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Chapter 6
Microfluidic Device for the Rapid
Oxygen Desaturation of
Hemoglobin in Red Blood Cells: A
Tool for Studying
Oxygen-Dependent ATP Release
6.1 Introduction
Red blood cells (RBCs) play an important role as the carrier of oxygen (O2) in the circu-
latory system. They are also thought to be involved in the local regulation of O2 supply
through the O2-dependent release of ATP [1–4]. By this mechanism, ATP is released
through pannexin-1 channels in the RBC membrane in response to low hemoglobin oxygen
saturation (SO2). The intraluminal ATP then binds to endothelial P2Y2 receptors causing
a conducted vasodilatory response to increase local blood flow [2, 5–9]. In addition to O2
desaturation [1, 10], RBCs release ATP in response to numerous other stimuli, including
shear-stress [11], pH [1] and osmotic pressure [12]. Although the mechanisms for the release
of ATP from RBCs have been extensively studied [11, 13–15], the role of ATP release as a
mechanism for O2 regulation remains unclear.
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One important consideration in the regulation of O2 is the time required for ATP to be
released from the RBCs following desaturation. Since the RBCs are in motion, the location
of ATP release is dictated by RBC velocity and ATP release time. Thus, the dynamics
dictate the spatial acuity of this regulatory mechanism. Understanding the dynamics of
this process could not only have implications in the understanding of oxygen regulation,
but may also play a role in the investigation of disease since O2-dependent ATP release has
been shown to be impaired in diseases such as type II diabetes [14, 16] and sepsis [17].
The objective of this study is to develop an experimental system to control the spatial
oxygenation of isolated RBCs in vitro to facilitate the measurement of the dynamics of
O2-dependent ATP release. To measure the dynamics, a similar approach to Wan et al.
[18] can be used, where they measured the dynamics of shear-dependent ATP release from
RBCs using a microfluidic device. In their setup, they used a microfluidic device with a
constriction to cause a spatial increase in shear stress to stimulate the release of ATP. ATP
was measured using a firefly luciferase assay and the position of the signal relative to the
change in shear was related to ATP release time. In the place of the constriction, we will
stimulate the release of ATP by using an O2-permeable window interfaced with a gas ex-
change device to cause a rapid change in SO2.
This system was first proposed in Sove´ et al. [19], where we extensively modelled the ex-
perimental design to see if such a setup would be sensitive enough to detect ATP release
time from RBCs. The computational model consisted of an idealized microfluidic device
whose walls were impermeable to O2, but which contained an O2-permeable window to
cause the rapid change in O2. The computational model not only simulated the transport
of O2 in the microfluidic device, but also the release of ATP and subsequent detection.
This confirmed that the experimental design was theoretically feasible and that we could
measure ATP release time. Additionally, it demonstrated that the relationship between the
ATP concentration and the luminescence from the firefly luciferase was not straightforward.
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While the idealized design was deemed sufficient for our study, fabrication techniques for
oxygen-impermeable materials such as glass are often expensive and require specialized
equipment. Therefore, we revised our design to be cost-effective and easier to manufacture.
Due to the simplicity and cost effectiveness of PDMS-based microfabrication techniques,
we chose to use PDMS (polydimethyl siloxane), a highly O2-permeable material, for the
primary substrate of the device. In order to cause the localized change in O2, we needed
to interface the device with an O2 impermeable material with a window to allow for gas
exchange. Since this design differed significantly from the original idealized design, we used
a 3D computational model of O2 transport to confirm that we could still cause a rapid
change in O2 [20]. This model also allowed us to optimize the device geometry to maximum
the change in O2.
The current study presents the fabrication of an experimental system that can cause a rapid
change in RBC SO2 for the measurement of the dynamics of O2-dependent ATP release
from RBCs. We quantify the changes in SO2 using a dual-wavelength microscopy system
to demonstrate the ability of the device to cause rapid and local desaturation. Finally, we
quantify the sensitivity of our system by determining the minimum ATP concentration we
can measure.
6.2 Methods
6.2.1 Gas Exchange Chamber
The gas exchange chamber design was based on previous work [21]. It was comprised of a
microscope stage insert, a gasket to form the side walls of the gas channel and a platform
for the inlet and outlet of the channel (see Figure 6.1); these components were designed
in FreeCAD and 3D printed. The bottom of the channel was closed by a replaceable glass
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slide and the top of the channel was closed by a custom, laser-cut glass slide with a square
window (1x1 mm) for gas exchange using a process described in [22]. The components were
assembled together using vacuum grease to ensure no gas leakage.
Stage 
Insert
Inlet and  
Outlet
Gas Channel  
Gasket
Figure 6.1: Three dimensional CAD model of gas chamber components. The inlet/outlet mount,
gas channel gasket and stage insert were 3D printed. The gas channel is sealed on the bottom with
a glass slide and on the top with a laser-cut glass slide.
A PDMS microfluidic device (fabrication described in Section 6.2.2) was aligned with the
gas exchange window such that the RBC flow is perpendicular to the gas flow. A schematic
of the microfluidic device-gas channel interface is shown in Figure 6.2.
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Figure 6.2: Schematic of the microfluidic device with gas chamber interface. Red arrow indicates
the direction of RBC flow. The gas channel flow is orthogonal to the RBC flow.
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6.2.2 Microfluidic Device
Fabrication: Microfluidic devices were fabricated with poly-dimethyl siloxane (PDMS;
Dow Corning Corporation Sylgard® 184) using impression molding similar to techniques
described in [23–25]; the master was machined from acrylic by micro-milling using a stan-
dard three-axis CNC mill (TrakK3SX-3 with ProTrakSMX control module; Southwestern
Industries Inc.). It was designed with removable walls to facilitate the removal of PDMS
from the master (Figure 6.3). PDMS was mixed in a 10:1 ratio of prepolymer base to cross-
linking agent. Liquid PDMS was poured into the master and cured at 60 °C for 90 minutes.
After curing, it was removed from the mold and trimmed to the final shape. The bottom of
the channel was fabricated by spin-coating PDMS at 2000 rpm for 60 seconds onto a glass
slide following methods by [23–25] (Figure 6.3). The two components were joined using the
partial curing method described in [25]. In this method, the spin-coated layer was partially
cured at 50 °C for 29 minutes and the bond was formed by bringing the two components
into conformal contact with no external pressure; the assembled device was cured at 60 °C
for 90 minutes. Cured devices were carefully peeled away from the glass slide taking care
not to break the thin PDMS bottom. Once fully cured, the microfluidic devices were placed
firmly on the glass exchange surface to form a temporary bond held together by Van der
Waals forces.
Design considerations: To optimize the rapid desaturation of the RBCs in the microflu-
idic device, we used a 3D O2 transport model of O2 in the microfluidic device [20]. The
model predicted that channels with a larger height to width ratio were able to cause a large
drop in PO2 in the channel. This consideration was weighed against the stability of high
aspect ratio PDMS channels. Resolution of the micro-milling system was also a considera-
tion. Smaller channels could be obtained by photolithography, though micro-milling was a
cheaper alternative for prototyping. In this study we used a channel that was 500 µm high
by 300 µm wide (Figure 6.4). The model also suggested that the PDMS spin coat layer
should be made as small as practical. Various spin-coating speeds were used to produce
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Figure 6.3: Schematic of the fabrication process. Panel A shows a 3D CAD model of the master
to form the PDMS channel. Step 3 shows the removable walls of the master which facilitates PDMS
removal. Panel B shows a schematic of the fabrication process. PDMS is added to the master, cured
and removed from the master. PDMS is spin-coated to a glass slide where is it partially cured. The
two pieces are brought into conformal contact and fully cured.
PDMS spin coats in the range of 5 to 100 µm; the devices were peeled from the glass surface
and inspected for tears in the membrane. The thinest, practical PDMS spin coat layer was
approximately 15-25 µm.
6.2.3 Experimental Setup
Whole blood was collected from the arterial line of anesthetized Sprague-Dawley rats into
a heparinized vacutainer tubes. RBCs were isolated by centrifugation (2000 rpm for 3 min-
utes) and suspended in a physiological buffer solution (2.545 mg/mL (CH2OH)3CNH2, 8.210
mg/mL NaCl, 0.350 mg/mL KCl, 0.295 mg/mL CaCl22H2O, 0.290 mg/mL MgSO47H2O,
5.000 mg/mL bovine albumin, 1.000 mg/mL D-glucose; pH of 7.4). Centrifugation and
resuspension were repeated three times to ensure the solution was free of clotting agents.
The RBC solution was driven through the microfluidic device via polyethylene tubing
(PE50); the flow rate was controlled by gravity feed. The system temperature was moni-
tored using a thermocouple and controlled to 37 °C using a heat lamp; the heat lamp was
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Figure 6.4: Micrograph of the microfluidic device. Panel A shows a 10X micrograph of the mi-
crofluidic device assembled with the glass slide with the gas exchange window (1×1 mm). Panel B
shows a 20X micrograph of the device cross-section orthogonal to the flow direction. The channel
dimensions are approximately 500×300 µm. The PDMS spin coat layer thickness varies between
approximately 18-28 µm.
turned off during capture to prevent optical artifacts.
6.2.4 RBC SO2 Measurement
RBCs were imaged on an Olympus IX-81 microscope at 20X magnification. Images were
captured at approximately 30 frames per second using a Hamamatsu digital camera (ORCA
Flash4.0). The transmitted light was split into two using a beam splitter (Cairn Optosplit
Bypass) to two different 10 nm band pass filters centred at 442 nm and 454 nm. Each beam
of filtered light was projected onto one half of the digital camera charged coupled device
(CCD). In this configuration, both filters are recorded simultaneously.
Image analysis was done in MATLAB 2016b (MathWorks Inc.). Hemoglobin oxygen satu-
ration of RBCs was determined using the ratio of optical densities as described in [26]. The
optical densities were calculated using the diffusion-based inpainting method described in
[27]. The high spatial resolution of the Hamamatsu cameras enabled the calculation of SO2
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on a pixel-by-pixel basis.
Briefly, SO2 can be calculated from the ratio of optical densities according to
SO2 =
b1 − b2R
a2R− a1 (6.1a)
ai = εHbO2 (λi)− εHb(λi) (6.1b)
bi = εHb(λi) (6.1c)
R =
OD(λ1)
OD(λ2)
, (6.1d)
where OD(λ) is optical density at wavelength λ; λ1 is 454 nm and λ2 is 442 nm. εHbO2 and
εHb(λi) are the extinction coefficients of fully oxygen saturated and desaturated hemoglobin,
respectively. Figure 6.5 shows the hemoglobin extinction coefficients as a function of wave-
length for fully oxygen saturated and fully oxygen desaturated hemoglobin, as tabulated in
[28].
Optical densities of individual RBCs were calculated on a pixel-by-pixel basis; this was
done by capturing stationary RBCs on the bottom surface of the microfluidic in two fields
of view, one centred at the beginning of the window the second centred at the end of the
window. The median optical density for each RBC was reported. RBCs were not included
in the calculation if they were obscured by other objects in the image.
6.2.5 ATP Measurement
ATP concentrations were measured using a luciferin and luciferase cocktail. 5 mg of D-
luciferin (Sigma-Aldrich Co.) was diluted into 10 mL of physiological buffer solution. 20
mg of luciferase (Sigma-Aldrich Co.) was diluted in 2 mL of physiological buffer. The
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Figure 6.5: Extinction coefficients of fully oxygen saturated and fully desaturated hemoglobin as
a function of wavelength. The black dashed lines indicate the wavelengths used in this study. Data
were compiled from [28].
luciferin and luciferase dilutions were mixed one-to-one to produce the final mixture; the
mixture was allowed to stand for 20 minutes before use. ATP standards were prepared by
serial dilution of 5 mg of ATP sodium salt in 1 mL of H2O. Measurements were made using
either a QuantEM EMCCD digital camera or a Photon Technology International D-104
photometer.
125 µL of luciferase cocktail was added to a blackout chamber placed over the objective of
the microscope. 250 µL of ATP was added after a one minute baseline recording. We used
a 15 s exposure for the EMCCD camera and a 1 s exposure for the photometer. Measure-
ments were made using a 4X objective in a dark room. In both methods, the peak intensity
was compared to the baseline.
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6.3 Results
6.3.1 SO2 Measurements
As discussed in Section 6.2.4, RBC SO2 can be measured using the optical properties of
RBCs. Specifically, it can be calculated from the ratio of optical densities at two wave-
lengths, where optical density is given by the logarithm (base 10) of the ratio of incident
light intensity to transmitted light intensity. The transmitted light intensity is measured by
the pixel intensity, and incident light intensity is estimated using diffusion-based inpaint-
ing as described in [27]. Figure 6.6 shows 20X microscopy images of stationary RBCs at
the bottom surface of the microfluidic device at two wavelengths (442 and 454 nm). This
figure visibly shows a change in red blood cell absorption in the 442 nm wavelength. Very
little change can seen in the 454 wavelength; this is because at this wavelength, hemoglobin
absorption is close to isosbestic (i.e. independent of SO2; see Figure 6.5). This figure
demonstrates that RBCs exposed to low oxygen over the window have a higher optical
density as would be expected for desaturated cells.
Median RBC optical densities of individual RBCs as a function of position downstream in
the microfluidic device are shown in Figure 6.7. Data were taken from two fields of view at
the beginning and end of the exchange window; data in the middle of the window were not
included since no fiducial markers were present to allow for the spatial positioning of the
data relative to the window. Outside of the window, optical densities are similar in both
wavelengths, while inside the window there is an increase in optical density at the 442 nm
wavelength in the window and a decrease in optical density at the 454 nm wavelength. This
figure also shows the optical density ratio, R (optical density at 454 nm divided by optical
density at 442 nm). The optical density ratio begins high outside the window and drops
rapidly in the window; the optical density ratio starts to drop before the window.
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Figure 6.6: Images of RBCs in the microfluidic device are shown for wavelengths 442 nm (A)
and 454 (B) inside and outside of the oxygen exchange window. Due to the optical properties of
the microfluidic device, RBCs at the same depth inside and outside of the window are in different
focal planes. Thus for the purpose of this figure two images are stitched together to show inside and
outside the window at the same time.
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Figure 6.7: Optical density of red blood cells as a function of position downstream in the microfluidic
device. The top panel shows the optical density at 442 nm (blue) and 454 nm (red). The bottom
panel shows the ratio of the optical density at 454 nm to the optical density at 442 nm. The dashed
lines indicate the edges of the O2 exchange window.
To quantify the change in saturation, the optical density ratio can be related to SO2 using
the extinction coefficients of hemoglobin at both wavelengths (see Section 6.2.4). Figure 6.8
shows the relationship used to calculate SO2; it was calculated with Equation 6.1 using
the extinction coefficients of fully saturated and desaturated hemoglobin at 442 and 454
nm. It is important to note that this relationship assumes that the filters used are perfect
zero-width bandpass filters centred at their corresponding wavelengths; in reality, our filters
have non-perfect 10 nm bandpasses.
Figure 6.9 shows SO2 as a function of position. We displayed the solution to a simple 1D
analytical model of O2 transport described in [20] on the same axis to demonstrate that the
data are consistent with the physical model. Four free parameters were used to fit the data
(Pe, S1 and S2 from the model presented by Sove´ et al. [20] and a scaling factor to allow
the model to have saturations greater than 1). The Hill equation was used to convert the
model from oxygen tension to SO2 (N = 2.7, P50 = 37 mmHg). This figure demonstrates
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the rapid change in O2 in the channel. These results demonstrate the device’s ability to
rapidly desaturate the RBCs within 200 µm. SO2 values range from 1.13 before the window
to 0.02 in the window. The values greater than one are likely due to the simplifications
made in the optical density ratio-SO2 relationship.
Figure 6.8: Relationship between the ratio of the optical density at 454 nm to the optical density
at 442 nm and RBC SO2.
Figure 6.9: SO2 as a function of position downstream in the microfluidic device. Each data point
is calculated from the optical density ratios in Figure 6.7 using the relationship in Figure 6.8. The
black dashed lines indicate the position of the window. For comparison, the solution to a 1D model
of O2 transport proposed in [20] (red; Pe = 1, S1 = 6 and S2 = 300) is displayed on the same axis.
The model was scaled to fit the data.
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6.3.2 ATP Measurements
We performed ATP standard measurements to determine the minimum ATP concentration
we could detect. For this, ATP solutions of various concentrations were injected into a
blackout chamber with the luciferase cocktail. The corresponding light flux was measured
with either an EMCCD camera or a photometer. Figure 6.10 shows an example ATP stan-
dard curve measured with the EMCCD camera with a 15 s exposure. Each concentration
was repeated three times. This result indicates the lower limit of the detection of ATP is
between 1×10−8 and 1×10−7 M. Although designed to use with CCD camera, preliminary
tests with a photometer show increased sensitivity; using a 1 s exposure, the photometer
can read ATP concentrations as low as 1× 10−9 M.
Figure 6.10: ATP standard curve for EMCCD camera. Each data point represents the mean
pixel intensity of the peak frame minus the mean pixel intensity of the baseline frames. Error bars
represent standard deviation of the peak frame. The dashed line indicates the standard deviation of
baseline frames.
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6.4 Discussion
This work presents the design and fabrication of a microfluidic device designed to cause a
rapid spatial change in RBC SO2 for the measurement of O2-dependent ATP release from
RBCs. We demonstrate that this device is able to cause a large, rapid change in RBC
SO2 that is localized around the gas exchange window. To quantify the sensitivity of our
experimental system and in particular, to determine the practicality of using an EMCCD
camera for the measurement of ATP, we have determined the minimum ATP concentration
we can measure using our camera to be on the order of 1 × 10−7 M. Finally, we explored
the possibility of using a photometer to measure ATP release, since this was the method
Wan et al. [18] used; preliminary results suggest that this system would be more sensitive
than the EMCCD system.
The design of the device presented in this work was inspired by a similar design by Wan
and colleagues in 2008, where they measured ATP release time for the shear-dependent
release of ATP from RBCs using a microfluidic device. The shear stress was induced us-
ing a constriction in the microfluidic device such that there was a spatial change in shear
in a time-invariant flow. ATP concentration was measured at various positions along the
microfluidic device using a firefly luciferase assay with a photometer. In their setup, ATP
release time was determined by measuring the distance between the beginning of the con-
striction and the start of the increase in ATP concentration and using the average RBC
speed to get release time [18].
The objective of our current research is to adapt Wan’s experiment for the measurement
of ATP release time for the O2-dependent release of ATP from RBCs. Though there are
many similarities between the two protocols, inducing a rapid change in RBC oxygenation
is far from straight-forward. To cause the spatial change in O2, we proposed to replace
the constriction in the microfluidic device with a gas exchange window. However, due to
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the nature of molecular diffusion, ensuring the change is large enough and spatially con-
fined is a challenge. This challenge was first addressed using mathematical modelling of an
idealized microfluidic device to determine if the experiment was theoretically feasible [19].
In particular, we determined that we could induce a spatial change in RBC SO2 and that
we could calculate ATP release time from the resulting light signal. This model was also
used to demonstrate the sensitivity of the change in SO2, and as a result released ATP, to
various experimental parameters such as the channel height and flow rate. An important
consideration in the experimental design is to choose a flow rate that is slow enough to in-
duce a large enough change in O2 but fast enough to achieve a sufficient temporal resolution.
One of the largest impeding factors was the fabrication of the microfluidic device. The
device Wan used was fabricated in PDMS, which is one the most common materials for mi-
crofluidic fabrication in academic laboratories [24]. The concern is that PDMS is a highly
O2-permeable material, which complicates the predictions of the RBC desaturation made
with the idealized microfluidic device. To address this complication, a 3D O2 transport
model was used to optimize the geometric dimensions of the microfluidic device [20]. In the
current study, we developed the protocol to fabricate the PDMS-based microfluidic device
designed in [20].
To determine how effective the microfluidic device is at desaturating RBCs, we measured
SO2 in the device using a dual wavelength spectroscopy method. In our lab, these measure-
ments are typically made in our intravital video preparation to assess capillary oxygenation
[21, 29]. In these protocols, SO2 measurements are made for in-focus RBCs flowing single
file through a capillary, and incident light intensity is calculated as the maximum intensity
in a sequence of images. Adapting these methods for use in vitro presents several challenges.
Firstly, in the intravital studies, RBCs are deformed as they flow through the capillaries.
When flowing freely in the microfluidic device, they are not deformed and lens the back-
ground light. Additionally, RBCs in the microfluidic device change focal planes, making it
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difficult to choose a focal plane for the measurement the optical densities of moving RBCs.
Therefore, we decided to only measure SO2 of stationary RBCs on the bottom surface of the
microfluidic device; these RBCs experience the largest change in SO2 while flowing RBCs
deeper in the channel will experience a smaller change. Since the background intensity of
lensed and stationary cells cannot be done using the maximum intensity image, we instead
use the newly proposed inpainting method [27].
Ultimately, the device should have the temporal resolution to measure ATP release time.
For O2-dependent release, ATP release time was suggested to be less than 500 ms based on
the transit time of RBCs in an isolated arteriole preparation exposed to low O2 [2]. If it
is similar to that of shear-dependent release, it is likely to be between 25-75 ms as found
in [18]. Since ATP release time is measured by a spatial displacement, temporal resolution
is affected by two factors (1) the spatial resolution of the detector and (2) the RBC ve-
locity. In the study by Wan et al., the average RBC velocity through the constriction in
their channel was 60 mm/s; this rapid RBC velocity gave them a large temporal resolution.
In our system, RBC velocity influences SO2 such that a larger velocity reduces the drop
in SO2 [19, 20]. Additionally, high RBC velocity results in high shear stress which may
elicit a shear-dependent response. Therefore, using a large RBC velocity is problematic in
our application, limiting our temporal resolution; thus, this application requires excellent
spatial resolution of the detector. In our system, preliminary tests were done using an
EMCCD digital camera with a CCD array of 512 by 512 pixels. At 4X magnification, this
corresponds to a spatial resolution of approximately 3.5 µm. Assuming an average RBC
velocity of 0.08 mm/s, this corresponds to a 44 ms temporal resolution.
A final consideration is whether the detector has the sensitivity to measure the resulting
concentration of ATP from O2-dependent release. We have determined that the detection
limit of the EMCCD camera is of the order of 1×10−7 M. Wan et al. reported peak concen-
trations on the order of 1×10−6 M in their device. If the O2-dependent mechanism releases
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at a similar rate, the system can detect it; this assumes the number of RBCs affected by the
stimulus is similar in both devices. An alternative to a CCD array is to use a photometer,
as in [18]. However, to achieve a high spatial resolution throughout the channel, numer-
ous closely spaced point measurements are required. With a photometer, this procedure
requires manually translating the detector along the channel. Using a CCD array allows
for the simultaneous capture of point measurements of a large region of the channel, but
is less sensitive than a photometer. Therefore, if the CCD array is not sensitive enough to
measure the ATP signal, a photometer may be used.
Using this device to measure ATP release time will strongly support the hypothesis that
RBCs release ATP in response to desaturation. Recent reports in the literature have sug-
gested that hemolysis may responsible for most or all ATP release measured in vitro due to
hypotonic shock, shear stress, and hypoxia [30, 31]. This device can rule out hemolysis as
a cause, since cell lysis would not occur in a time-invariant manner; thus the steady-state
signal would only reflect the O2-dependent release.
In addition to determining ATP release time, this device could be used to study the dynam-
ics of O2-dependent ATP release in both health and disease. For example, healthy RBCs
could be used with signalling pathway inhibitors to help determine the mechanism for ATP
release. Further, since impairments in ATP release have been linked to various diseases
[14, 16, 17], this device could be used as a screening tool.
In summary, we have developed an in vitro tool to rapidly desaturate RBCs spatially for
the purpose of measuring the dynamics of O2-dependent ATP release. The device is capable
of causing a rapid and large spatial desaturation. Our CCD camera approach is able to
detect ATP concentrations on the order of 1 × 10−7 M. This work presents an important
step forward in the study of O2-dependent release of ATP from RBCs as a mechanism for
O2 regulation in the microcirculation.
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Chapter 7
Final Summary
The regulation of O2 distribution in the microcirculation is a complex control system that
can adjust vascular tone to alter the distribution of RBCs to precisely match O2 supply with
O2 demand. Numerous researchers provide evidence for the existence of an O2-dependent
mechanism for O2 regulation, however, the location of the O2 sensor remains unclear [1].
The goal of this thesis was to develop tools to facilitate the study of the regulation of
O2 distribution in the microcirculation by applying concepts in mathematics, physics and
engineering. In this thesis, we took a two-tiered approach. First, at the level of the mi-
crovasculature, we developed a gas exchange device that allows for the local manipulation
of capillary RBC SO2 in vivo to study the spatial dependence of ATP release. Secondly,
to study one of the proposed sensors, the RBC, directly, we developed an in vitro device
capable of causing rapid changes in SO2. Due to the challenges associated with the develop-
ment and analysis of the experimental tools, extensive computational modelling was done.
Challenges in measuring RBC SO2 in the in vitro microfluidic device motivated the need
for an image processing technique to calculate the RBC SO2 from light microscopy images;
this new technique was also applicable to measurements in vivo. At a high level, this thesis:
1. presents the novel design for a modular gas exchange platform that was demonstrated
to cause perturbations in RBC SO2 in vivo both experimentally and computationally,
2. demonstrates that localized changes in RBC SO2 in an isolated group of capillaries
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can elicit a flow response,
3. proposes a experiment to measure the dynamics of O2-dependent ATP release from
RBCs using a novel microfluidic device design,
4. explores the feasibility of this experimental approach using a comprehensive mathe-
matical model of the experimental system,
5. presents a computational model of O2 transport throughout the wall and channels
of the microfluidic device proposed above for the optimization of various geometric
parameters,
6. demonstrates the use of digital inpainting to calculate the incident light intensity in
microscopy images for calculation of RBC SO2 overcoming many deficiencies with the
methodology currently used in the field,
7. presents the construction and experimental validation of the microfluidic device to
cause a localized spatial deoxygenation of RBCs.
In this chapter, the main results from each study of this thesis are summarized, followed by
a discussion of the future directions of this work.
7.1 Summary of Results
In 2011, our lab developed an O2 delivery platform capable of causing changes in capil-
lary O2 saturation (SO2) limited to a small area of tissue in an intravital video microscopy
system [2]. Although the O2 exchange platform induced changes in red blood cell (RBC)
SO2, corresponding changes in supply rate were not reported [2]. This method was altered
to increase the surface area for exchange; a 100 µm diameter circular exchange area was
replaced by a 1000 by 200 µm rectangular area. As predicted by computational studies [3],
this modification was able to elicit a vascular response despite causing similar changes in
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capillary SO2 [4]; the difference was the number of affected capillaries. Although this setup
was able to elicit a vascular response to O2, ideally we would have a more localized stimu-
lus. Another challenge with the previous apparatus is that it could only resolve capillaries
within 60 µm from the surface of the tissue.
In Chapter 2, we developed an O2 delivery platform with a smaller exchange area that
is also thin enough to allow us to focus on capillaries deeper throughout the muscle. A
GPU-accelerated, 3D O2 transport model of diffusion through the tissue was implemented
to estimate the extent of the change in tissue oxygenation. The O2 exchange platform is
able to cause changes in RBC SO2 of capillaries close to the window. Further, these changes
resulted in corresponding changes in RBC supply rate. The computational model predicted
the drop in O2 is confined to 80 µm from the edge of the window. Overall, we have de-
veloped an O2 delivery system that is capable of causing localized changes in SO2 which
can be used to further investigate microvascular O2 regulation. The observation that RBC
supply rate was tightly linked to the imposed changes in RBC SO2 inspired our interest in
the role of RBCs in O2 sensing and regulation.
RBCs have been proposed to be a sensor in blood flow regulation through the O2-dependent
release of ATP, a potent vasodilator. Chapters 3, 4 and 6 focus on the development of an
experimental device that will allow for the rapid desaturation of RBCs in order to study
this potential mechanism in isolation. In 2008, a study at Harvard measured the dynamics
of shear-dependent ATP release from RBCs using a microfluidic device with a constriction
in the channel to increase shear stress [5]. The brief period of increased shear stress resulted
in ATP release within 25 to 75 milliseconds downstream of the constriction. Thus our goal
is to apply a similar approach to determine the dynamics of O2-dependent ATP release. In
the place of the constriction, an O2-permeable membrane interfaced with a low O2 gas ex-
change chamber would be used to decrease the SO2 of the RBCs flowing through the channel.
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Chapter 3 describes the first stage in achieving this goal: the development of a computa-
tional model of the proposed experimental system to determine the feasibility of altering
SO2 rapidly enough to measure ATP release dynamics. The computational model was con-
structed based on hemodynamics, molecular transport of oxygen and ATP, kinetics of lu-
ciferin/luciferase reaction for reporting ATP concentrations, light absorption by hemoglobin,
and sensor characteristics. A linear model of oxygen saturation-dependent ATP release with
variable time delay was used in this study. The computational results demonstrate that
a microfluidic device with a 100 µm deep channel will cause a rapid decrease in oxygen
saturation over the oxygen-permeable membrane that yields a measurable light intensity
profile. The simulation also demonstrates that the complex dynamics of ATP release from
erythrocytes with ATP degradation by luciferin/luciferase in a flowing system results in
light intensity values that are not directly related to ATP concentrations. A computational
model is required for proper interpretation of experimental data.
The idealized microfluidic device described in Chapter 3 assumed the device was fabricated
using an O2-impermeable material with an O2-permeable window for gas exchange. Consid-
erations to cost and ease of fabrication motivated a new design. With the fast emergence of
microfluidics, non-specialist are able to rapidly prototype microfluidic devices in PDMS [6].
Unfortunately, this revision had a substantial impact on our original design, since PDMS
is highly O2-permeable. This motivated the need for a flexible 3D computational model of
O2 transport.
In Chapter 4, oxygen transport simulations were used to optimize the geometric design
parameters for a similar system which is easier to fabricate using PDMS soft lithography
techniques. The system is composed of a microfluidic device stacked on top of a large, gas-
impermeable flow channel with a window to allow gas exchange. The microfluidic device is
fabricated using soft lithography in polydimethyl-siloxane, an oxygen-permeable material.
Our objective was twofold: (1) optimize the parameters of our system and (2) develop a
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method to assess the oxygen distribution in complex 3D microfluidic device geometries. 3D
simulations of oxygen transport were performed to simulate oxygen distribution throughout
the device. The simulations demonstrate that microfluidic device geometry plays a critical
role in molecule exchange, for instance, changing the orientation of the short wide microflu-
idic channel results in a 97% increase in oxygen exchange. Since microfluidic devices have
become a more prominent tool in biological studies, understanding the transport of oxygen
and other biological molecules in microfluidic devices is critical for maintaining a physiolog-
ically relevant environment. We have also demonstrated a method to assess oxygen levels
in geometrically complex microfluidic devices.
To experimentally validate the ability of the microfluidic device to desaturate RBCs, SO2
can to be measured in the device by taking advantage of spectroscopic properties of hemoglobin.
When this technique is applied to transmission microscopy, the calculation of saturation re-
quires determination of incident light intensity at each pixel occupied by the RBC; this value
is often approximated from a sequence of images as the maximum intensity over time. This
methods often fails in our microfluidic system since RBCs in the microfluidic device tend to
lens light due to the biconcave shape of the RBC. This lensing artifact causes a ring of high
intensity light around the RBC, causing the maximum intensity-based algorithm to fail.
RBCs in capillaries must deform to pass through the narrow vessel, in this configuration
there are fewer artifacts, thus this problem is less confounding to in vivo measurements. In
addition, the maximum intensity-based method is not suitable to measure SO2 of stationary
cells.
Therefore, in Chapter 5, we propose a new way of approximating incident light intensity
using digital inpainting. The proposed method estimates incident light intensity with a
percent error of approximately 3% on average, which exceeds the accuracy of the maximum
intensity based method in most cases. The error in incident light intensity corresponds to
a maximum error of approximately 2% saturation. Therefore, though this new method is
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computationally more demanding than the traditional technique, it can be used in cases
where the red maximum intensity-based method fails (e.g. stationary cells), or when higher
accuracy is required. It can also be used to measure SO2 in the microfluidic device.
With all of the required tools in place, the objective of Chapter 6 was to present the design
and development of the experimental system to control the spatial oxygenation of RBCs
facilitating the measurement of the dynamics of ATP release. The experimental system con-
sisted of two parts: our previously developed micro-delivery gas exchange platform and an
O2-permeable microfluidic device designed and refined using computational modelling. The
gas exchange chamber was used to cause a localized change in O2 in the microfluidic device
such that the flowing RBCs suspended in physiological buffer would be experience a rapid
change in O2. To quantify the change, the newly developed inpainting method was used.
RBCs in the microfluidic device were rapidly desaturated to near-zero SO2. In future work,
a firefly luciferase assay can be used to measure the position of ATP released from RBCs,
which can then be used to determine ATP release time. We determined that the EMCCD
camera is capable of detecting changes in ATP as low as 1× 10−7 M; the photometer offers
even better sensitivity detecting down to 1 × 10−9 M using a short exposure time of 1 s
at the cost of lower spatial resolution. In summary, we have developed an experimental in
vitro system to impose a spatial deoxygenation of RBCs in a steady flow microfluidic device
to study the dynamics of O2-dependent ATP release from RBCs.
7.2 Future Directions
In this thesis a variety of tools were developed to study the regulation of O2 in the micro-
circulation. As such, this thesis serves as a basis that future researchers can use to answer
exciting questions in physiology. The following section outlines potential applications of the
developed tools.
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Chapter 2 presented a device for the local desaturation of RBCs in capillaries in vivo. This
device is capable of causing changes in O2 limited to a handful of capillaries. With such
a device, one could explore the potential location of the O2 sensor in the microcirculation.
For example, this device could be used to probe regions of the muscle absent of capillaries
to determine whether the sensor may be extravascular. Further, consistent with the ATP
release hypothesis, one could use this device to stimulate capillaries in one microvascular
unit, to see whether a flow response is elicited in other micro vascular units attached to
the same or different arterioles. This device could also be used to determine whether there
are other factors controlling flow regulation other than passive rheology, such as pericytes.
One could manipulate the SO2 of multiple capillaries coming from the same arteriole to
determine if the distribution of flow rates remains constant. Thus, this device allows for a
number of future studies directed at perturbing the local oxygen microenvironment in the
microcirculation.
Chapters 3, 4 and 6 presented the development of a device that could be used to measure
the dynamics of O2-dependent ATP release. This device would not only allow for the mea-
surement of ATP release time, it could also serve as a confirmation that the ATP released is
not due to hemolysis. However, before this device can be implemented, there are challenges
that still need to be addressed.
For example, one challenge in measuring ATP is that hemoglobin absorption in the emission
range of the luciferase reaction is high and O2-dependent [7]. The firefly luciferase reaction
emits light centered at 560 nm at 25 °C [8]. At this wavelength, hemoglobin absorbs more
light when it is fully oxygen desaturated and thus, the same ATP concentration would
appear to produce more light in RBCs exposed to high O2. Furthermore, the wavelength
emitted is also temperature-dependent and therefore absorption by hemoglobin would also
have a temperature dependence. This may also have an impact on other in vitro measure-
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ments of ATP release. This difficulty was overcome in the study by Jagger et al., where
whole blood was desaturated, but the ATP assay was perform on a dilution of the sample
[9]. At low hematocrit, the absorption of light would be less, thus the effect of the oxygen
dependence of the absorption would be minimal. Therefore, further refinements need to be
made to the experimental protocol in order to measure ATP release dynamics.
After measuring the dynamics of ATP release in healthy blood, one could continue to ex-
plore the dynamics of ATP release in various pathological conditions. There have been
various indications in the literature that ATP release may be impaired in various diseases
including type II diabetes [10] and sepsis [11]. The system developed in this thesis may be
used to determine whether the dynamics are also affected in disease; if so, it could be used
clinically as a diagnostic tool.
As well as having clinical applications, the device can also be used to investigate the sig-
nalling pathway within the RBC. Some preliminary work done using a computational model
of the cellular pathway for ATP release suggests the dynamics of ATP release would be al-
tered when specific mechanisms in the pathway are perturbed (data not shown). In this
preliminary work, a computational model of the pathway was developed by [12]. The com-
putational model was then applied to the model of the experimental system developed in
Chapter 3, replacing the ATP release module. This work had several interesting insights
which can be pursued in the future. Firstly, ATP release turn-off time was different than
ATP turn on-time. Secondly, impairment of specific mechanisms in the pathway leads to
altered ATP release time; ATP turn-off time was affected more than ATP turn-on time.
Therefore, computational modelling in conjunction with this microfluidic device could allow
for the elucidation of the mechanism for ATP release.
In addition to the experimental tools, a set of computational tools were developed in order
to design, evaluate and understand the experimental tools. For instance, in Chapter 4, a
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3D model of O2 transport was implemented using the finite element method to evaluate
the efficacy of O2 exchange in O2-permeable microfluidic devices. This code was developed
to be modular and can be used for any geometry. This program can be used in the devel-
opment of future devices. Additionally, Chapter 5 describes an algorithm that estimates
incident light intensity for the calculation of RBC SO2. One important accomplishment
of this algorithm is its ability to calculate SO2 of stationary RBCs. This was useful for
the quantification of the change in SO2 in the microfluidic device, since we could measure
SO2 for cells adhering to the bottom walls of the device. Further, in sepsis, there are often
very low flow or stopped flow vessels [13, 14], for which this algorithm could be used to
determine SO2. In future work, an automated RBC detection method can be implemented
to facilitate the automation of inpainting. Once automated, inpainting can be incorporated
into the existing analysis software for the calculation of SO2.
7.3 Conclusion
In summary, this thesis has developed both in vivo and in vitro experimental tools, as well
as computational tools to study the regulation of O2 distribution in the microcirculation.
Specifically, we have developed a microdelivery gas exchange platform to cause localized
changes in capillary RBC SO2 that result in a vascular flow response, and a microfludic
device capable of rapidly desaturating RBCs to facilitate the measurement of the dynamics
of O2-dependent release of ATP from RBCs. To guide the development of these exper-
imental devices, we also developed a set of computational and analytical tools including
mathematical models of the physical devices and a novel approach to measuring RBC SO2.
Together these tools provide novel methodology that enable the pursuit of new avenues to
advance the study of microvascular O2 regulation.
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